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ABSTRACT 
Effect of Heavy Lifting with a Head Strap on the Pelvic Floor Across the 
Menstrual Cycle 
By Yvonne Biswokarma 
Doctor of Science Graduate Program in Physical Therapy 
Loma Linda University, December 2016 
Dr. Everett Lohman III, Chairperson 
Dr. Karen Brandon, Chairperson 
Background: Pelvic organ prolapse (POP) occurs in 10% of women in Nepal, 
even 6% of nulliparous women have symptomatic POP.1 This may be linked to the heavy 
lifting tasks performed by women using a  head strap.2 This study explored  the impact of 
hormonal changes on the pelvic floor when performing these tasks during each phase of 
the menstrual cycle.  Methods: The study included 22 female Nepali participants with a 
mean age of 27.4(3.6) years; all were from rural villages and frequently carried with a 
head strap.   Using intravaginal pressure transducers (IVT), the mean change in intra-
abdominal pressure (IAP) was found to be 37.1(4.3) cmH20 when lifting a load with a 
mean weight of 19.8(3.2)kg using a head strap.  Lifting tasks were simulated with 
isometric ballistic lifts against a head strap secured to the plith with the participant lying 
supine.  The mean increase in IAP from rest was 31.6(2.1)cmH20.   Displacement of the 
pelvic floor was measured by transperineal ultrasound.  Mean displacement of the pelvic 
floor at ovulation was 5.1(0.4)mm and a mean of  5.9(0.4)mm during the early follicular 
phase (p 0.03).  Conclusion: during the early follicular phase, when basal body 
temperature and beta estrogen are lowest, the compliance of the pelvic floor is greatest.  
Repetitive lifting during this time may predispose some woman to POP.  
 xiv 
Key terms: prolapse, nulliparous, pelvic floor, lifting, menstrual cycle, laxity, 
compliance, elasticity, stiffness. 
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CHAPTER 1 
LITERATURE REVIEW 
 
Background for At-Risk Population  
The population of interest in this study was women of reproductive age living in 
Nepal.  
Pelvic organ prolapse (POP) has been noted to be a significant health problem in Nepal, 
with from 10 -25% of women affected 3.  The 2011 Nepal Health Demographic Report 
cites 10% of women have POP.  Seven percent of women of reproductive ages 15-49 
have POP, and 6% of nulliparous women have symptoms of POP.  
In Nepal, 14% of women who developed POP did so as teenagers; the mean age 
of onset was  27 years, according to a  2006 study by the Institute of Medicine at 
Tribhuvan University, Kathmandu, Nepal.4  In contrast, the prevalence of symptomatic 
POP in western countries appears to be more common one to two decades later in life.5  
In Nepal, there is only a one percent difference in rates of symptomatic POP in 
the general female population and nulliparous women ages 15-49.1 Research by Dietz 
(2008)   showed that vaginal delivery was the prime risk factor for POP, specifically 
levator ani tears or avulsion occurring during childbirth, particularly with forceps.5   If 
traumatic injury during vaginal delivery were the main risk factor for POP, it seems 
unlikely that parous and nulliparous women of the same age groups would experience the 
condition at such similar rates. 
A review of the literature cited common risk factors of POP, including vaginal 
deliveries, 6 poor pre- and post-natal care, position at delivery.7 Non-pregnancy or 
delivery related factors included menopause,7 genetics, aberrant connective tissue 5,8 and 
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obesity.5  Factors related to child bearing do not account for the nearly identical rates of 
early onset POP among Nepali nulliparous women of the same age.  Obesity is an 
unlikely cause, since only 2.9% of Nepali adults are obese.9 However, risk factors shared 
by both parous and nulliparous women in Nepal are a relationship between POP and the 
inherent weakness of supportive connective tissue.10 Though this may account for a 
genetic predisposition for the condition found in some ethnic groups, it is not known if 
identified changes in collagen are the cause or effect of prolapse.11  
Though the influence of hormones, including relaxin and estradiol, on tissue 
laxity has been explored,10,12,13,14 a literature review fails to identify a clear cause for loss 
of support by the pelvic floor in the absence of lavator ani tears. Decreased estradiol at 
menopause is thought to cause a decline in the support provided by the pelvic floor.15  
However, little is known about cyclic changes in elasticity and compliance of the pelvic 
floor during the menstrual cycle and how it may influence the dynamic demands required 
in daily tasks. If cyclic changes on the pelvic floor are found to be a common risk factor 
for women during their reproductive years, this may help to explain the development of 
POP in nulliparous women.  Especially in Nepal where “Chhaupadi” is often 
practiced.2,16 This custom requires women to stay outside the house during menstruation 
and childbirth and forbids them from doing household chores such as cooking and 
religious duties.  However, they are still required to do outdoor tasks that involve lifting 
and carrying loads while they are menstruating.  This may lead to a disproportionate 
amount of heavy lifting during this part of their menstrual cycle. 
Nepal demonstrates a unique situation with woman developing POP earlier than 
in western counties, and vaginal delivery is not consistently a factor.  Menstrual cycles 
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have been shrouded with superstition in many cultures.  Chhaupadi, practiced in Nepal 
with its accompanying heavy lifting maybe a clue as to why POP develops early for 
Nepali women and even in nulliparous women.2  
 
Isometric Simulation of Head Bearing Load (ISHBL) 
Studies in Nepal frequently identify carrying of heavy loads as a risk factor in 
POP and lifting 2.5 kg or more (especially when squatting) is known to increase intra-
abdominal pressure (IAP) and create a downward force on the pelvic floor.17  In a study 
of 118 white women, normal mobility of the pelvic floor in nulligravid women, measured 
by descent of the bladder neck, was found to be 1.2-40.2 mm in a translabial ultrasound 
study of Valsalva maneuvers.18  However, this 2004 Dietz study did not control for 
menstrual phase, IAP, speed of movement, or the activation of pelvic floor muscles.  
We must also consider the compliance properties of the tissues, the reciprocal of 
elastic properties. Elastance allows tissue to resist distension and recoil to its original 
shape, and compliance is the ability of a hollow organ to distend and resist recoiling to its 
original shape.  Compliance equals the change in volume over the change in pressure. 
 
Increased elasticity should help maintain pelvic organ positions and resist 
deformation of the pelvic floor under pressure.  Increased compliance would allow the 
pelvic floor to deform more under pressure and leave the tissues stretched out and unable 
to support the pelvic organs in their positions. A more compliant pelvic floor would then 
be an inherent risk factor for pelvic floor dysfunction.19  
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Synergy motor patterns active in lifting and body position are other factors that 
could affect mobility of the pelvic floor. Gluteal muscles are involved in hip movement 
and stability during lifting, and have a synergistic effect on activity of the pelvic floor.20  
Activating the pelvic floor muscle  creates a negative or inward displacement of the 
pelvic floor; 21 therefore if the pelvic floor is not  intentionally activated but are 
synergistically active with the gluteal muscles while lifting this may  decrease  downward 
displacement of the pelvic floor during increased IAP during functional lifting tasks. On 
the other hand, compared to a supine position, standing has been shown to weaken pelvic 
floor muscle contractions and increase intravaginal pressure.22  Thus positioning and 
motor patterns must be consistent during task performance for controlled repeated 
measures comparisons of pelvic floor mobility.  
  
 
Figure 1. Young Nepali women carrying loads with  doko and namlo.  
Photo by Sudarshon Karki  
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Little is known about the impact of lifting on the descent of the pelvic floor 
among normal women performing functional lifting tasks unique to Nepal.  Typically 
loads are carried using a head strap as shown in Figure 1. There is limited information on 
safe lifting when loads are carried in this manner.  In accordance with Nepali 
governmental guidelines and Porter Progress recommendations, a 30kg load limit is 
placed  on porters using these lifting techniques.23  However, no guidance was found on 
preferable techniques or lifting methods specific to using a head strap. NIOSH lifting 
equation guidelines were all specific to carrying loads in the arms in front of the body. 
There are no studies which show the normal changes in IAP when a woman lifts 
using a doko, and how these lifts might affect her pelvic floor mobility. Another factor 
not being explored is the effect of the menstrual cycle on pelvic floor mobility. Further 
research is needed to look at the complex interplay of hormone physiology, the 
biomechanics of the pelvic floor, and intra-abdominal pressure when women in this 
population perform certain load-bearing, functional tasks.  Our study attempted to 
address these issues.  
 
Hormonal Effects of the Menstrual Cycle on Connective Tissues 
Levels of estradiol, the primary marker of the menstrual phase, increase around 
ovulation and stay elevated through the luteal phase and decline during the early 
follicular phase.24   
• Follicular phase: <20-145 pg/mL (184-532 pmol/L) 
• Midcycle peak(ovulation): 112-443 pg/mL (411-1,626 pmol/L) 
• Luteal phase: <20-241 pg/mL (184-885 pmol/L) 
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A woman’s estradiol levels decrease after menopause.  Research shows that 
decreased estradiol levels as low as 0-40 pg/mL have been linked to POP, since lower 
levels of estradiol weaken pelvic floor structures.15  However, there are no studies on 
changes in the pelvic floor across the menstrual cycle (<20-145 pg/mL), which at some 
points can be nearly as low as post-menopausal levels. Since hormonal fluctuations may 
be a factor affecting the tissue properties of the pelvic floor, mobility of the pelvic floor 
should be compared across all major phases of the menstrual cycle.   
There is a lack of consensus in the literature as to which menstrual phase may 
have more inherent risk for tissue injury. Ovulation is thought to increase risk of ACL 
injury due to higher estradiol levels, and some studies found this may promote ligament 
laxity. Park found increased laxity and decreased stiffness in the knee joint at ovulation.25 
The supportive structures of the pelvic organs have receptors for estradiol and other 
gonadal hormones, and may be affected by the cyclic changes in these hormones.10 
Lower estradiol levels have been shown to increase musculotendinous stiffness26 and 
decreased elasticity27 during menstruation.28   
Is increased stiffness a risk or a benefit?  Dietz asserts that increased stiffness may 
be protective for POP among post-menopausal women, and that vaginal stenosis is the 
result rather than prolapse.29 Dietz bases this on the observation that POP does not always 
progress with age and seems to even stabilize after menopause. To date, no studies were 
found that have evaluated the relationship between estradiol fluctuations in normal 
menstrual cycles and the stiffness or elasticity of pelvic floor tissues.  
Testing blood hormone levels are the ideal way to monitor hormone levels. 
Advanced Clearblue Ovulation tests (SPD Swiss Precision Diagnostics GmbH, Petit 
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Lancy, Switzerland) have been shown to be highly accurate in detecting levels of estrone-
3-glucuronide (E3G; one of the urinary metabolites of estradiol) and luteinizing hormone 
(LH) around ovulation as compared to other home based methods.30  These tests are less 
difficult for consumers to use without compromising accuracy.  
The follicular phase of the menstrual cycle is typically from the first day of 
menses to the LH surge, which marks ovulation. The luteal phase of the menstrual cycle 
is from ovulation to the beginning of the next cycle. Three representative points from the 
distinct phases could be described as:  
1. Within the first 4 days of menses (early follicular phase) 
2. Within 24-48 hours of peak fertility indication 
3. 6-10 days after LH surge  
From Figure 2, it is clear that the greatest contrast in terms of estrogen levels are 
days 1 through 6 in the menstrual cycle, and ovulation days. We would expect to see the 
greatest differences in tissue properties between these two phases.  
 
 
Figure 2. Häggström, Mikael (2014) Reference Ranges for Estradiol  
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Effects of Core Temperature 
Temperature  
Elastic properties of biological viscoelastic tissues are altered by temperature and 
loading rate. The temperature of tissue has been shown to affect its mechanical 
properties.31,32 Core body temperature is normally between 36-37.5°C.33 Temperature 
also is affected by the menstrual cycle;34 basal body temperature increases at the time of 
ovulation and remains elevated through the luteal phase. Therefore, vaginal temperature 
should be tested along with IAP to determine if temperature, along with other hormonal 
effects, impacts the displacement of the pelvic floor across the menstrual cycle. Basal 
body temperature is one half to one degree lower during the early follicular phase than 
after ovulation and throughout the luteal phase.  Temperature changes have been shown 
to affect the performance of other ligaments in the body when tested across the menstrual 
cycle.35  
During menstruation, when estradiol and temperature are at their lowest points, 
the net effect is decreased elasticity and temperature, with increased stiffness, 
inflammation, and pain in the pelvic structures, versus at ovulation, when estradiol and 
temperature are at their peak.36 In this study, we assessed  temperature changes  by taking  
continuous readings intra-vaginally with a fast response sensor (TSD202A, BIOPAC 
Systems, Inc. Goleta, CA , USA) attached to the IVT (Department of Bioengineering, 
University of Utah, Salt Lake City, Utah).   
 
Other Factors 
Also, pro-inflammatory cytokines are elevated during menstruation and correlated 
with premenstrual syndrome (PMS).36-38  For this reason, testing for pelvic floor mobility 
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across the menstrual cycle may be inhibited by pain and muscle guarding. Dysmenorrhea 
also could be a confounding factor in studies of normal pelvic floor movement. In 
addition, chronic cough due to respiratory conditions, smoking or asthma, as well as  
constipation, have been known to influence POP and may alter normal pelvic mobility.39  
 
Transperineal Ultrasound (US) 
Ultrasound (US) has been shown to be a valid tool for the measurement of pelvic 
floor and organ displacement or movement.40-44 Various methods of ultrasound imagining 
have been reviewed and addressed in the literature, such as transperineal US and 
suprabupic US and transabdominal ultrasound (TAUS); however, suprapubic TAUS was 
not chosen since the abdominal wall is not stationary during activity and breathing.45  For 
this reason, transperineal US was chosen as a way to visualize the pelvic floor structures 
and measure transitional movements. Consistent imaging strategies were used, and 
scripted instructions for all test activities were undertaken to collect the most reliable data 
possible. Compared to other methods, US has been considered a reliable method of 
visualization of pelvic floor morphology.42,46 The movement of the urethralvesicular 
junction with changes in IAP has been used as a marker of pelvic floor mobility.18  
Because positioning for the transperineal ultrasound imaging is difficult during squatting 
to standing movement, the US probe must be stabilized to produce accurate imaging. 
Also, displacements of the pelvic floor have been noted to be significantly different in 
supine versus upright positions;22 therefore simulating the positioning in functional tasks  
during testing of pelvic floor mobility is important for accuracy. Normal supine pelvic 
floor mobility while performing the Valsalva maneuver measured with translabial 
ultrasound was shown to vary widely from 1.2 – 40.2 mm.18  Perhaps much of this 
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variability was due to changes in the biomechanical properties of the tissue induced by 
fluctuations of estradiol across the menstrual phase.   
 
 
Figure 3. Pelvic Floor US image used in the study. 
 
 
Measurement of Intra-abdominal Pressure (IAP) 
Intra-abdominal pressure (IAP) rises during dynamic lifting activities.17,47 
Continuous monitoring of IAP would allow identification of peak IAP as it occurs with 
actual lifting of a typical load with head strap and the isometric simulation of head 
bearing lifting (ISHBL). The intravaginal pressure transducer (IVT) that was developed 
and validated at the University of Utah is ideal for measuring IAP in functional tasks.48,49 
This transducer was developed by the University of Utah and approved for use in 
research by the University of Utah Health Sciences Center Institutional Review Board.48 
The IVT is similar in size and shape to an O.B. brand tampon (see Figure 4). Women in 
initial trials have reported the IVT to be comfortable and that it did not impair 
movement.49 Normal IAP for women performing functional tasks was found to be 40-80 
cm H20.50,51 We found the peak-to-peak change in pressure with functional tasks to 
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typically range from 20 -100 cmH2O.  The IVT sensor, in conjunction with the use of 
BIOPAC modules and acquisition software, can allow for real-time IAP readings on the 
computer monitor. The IVT has been used in multiple positions for testing functional-
task IAP, including supine and transitional movements.50 The IVT calibration was done 
in Salt Lake City and the elevation is nearly identical to the testing location in Nepal. 
Sensors were not a cross contamination concern because they were placed in condoms 
while in use and treated with Cidex (ASP, Irvine, California) per manufactures 
instructions and rinsed in sterile saline prior to the next use. This is the protocol currently 
used in the operation theater at Scheer Memorial Hospital (the research venue) and also 
meets or exceeds the JHACO guidelines and manufactures recommendations for the 
sterilization of equipment that is reused with multiple patients.  
 
 
Figure 4. Photo of the IVT sensor in hand for size reference. 
 
 
Rationale for the Study 
Consistent excessive compliance or displacement at any one phase of the MC 
could indicate increased risk of tissue damage that could weaken support for pelvic 
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organs and predispose women to pelvic organ prolapse (POP). See Table 1 for list of 
common causes for POP and which are pertinent to the population in Nepal. 
 
Purpose 
To identify at least two phases of the menstrual cycle (MC) that are significantly 
different in the amount of displacement of the pelvic floor due to increased intra-
abdominal pressure (IAP) with isometric simulation of head-bearing lifting (ISHBL) in 
Nepali women of reproductive age. 
Specific aims of the study: This study will identify possible differences in the 
displacement of the bladder neck from rest while participants perform ISHBL at 
representative points in the menstrual cycle;  
1) Early follicular phase (menses days 1-4)  
2) Within 48 hours of ovulation  
3) Mid-luteal phase (7-10 days after ovulation) 
 
Hypothesis 
1) There is a statistically significant difference in the mean displacement of the 
ventral urethralvesicular junction (VUVJ) from rest to maximum IAP with 
ISHBL between at least two of the phases of the menstrual cycle. 
2) The higher the increase in IAP, the greater the descent in the VUVJ with 
ISHBL. 
3) Compliance of the pelvic floor will be greatest in menstruation.  
4) Engagement of the pelvic floor muscles (PFM) will be negatively correlated to 
pelvic floor displacement. 
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Table 1. Summary of the Risk Factors for POP, Comparing Nepal to the USA. 
 
POP Risk Factor in the literature  Considered a Special  
risk factor Unique to  
Nepal  
Rationale  
Vaginal Delivery  No  6% of nulliparous 
women have POP.1 
Vaginal delivery with forceps * No 90% of women 
delivered at home with 
unskilled birth 
assistants.4 
Delivery with unskilled attendants  No Overall, POP rates 
similar to Western 
countries when 
women delivered in 
hospitals.4,52 
Multiple vaginal deliveries  No 30% of women 
developed 
symptomatic POP 
after the  first delivery 
or even no delivery.4 
Genetic factors effecting collagen 
metabolism   
No As a country,  Nepal 
has similar rates of 
POP as compared to 
other Western 
countries so genetics 
is not an obvious 
difference.1 
Early age of marriage and child 
bearing  
Yes Nepali women may 
develop POP earlier 
than Western women 
because they typically 
have children six or 
more years earlier than 
in the US.9  
Gender discrimination / domestic 
violence  
No Domestic violence 
rates are the same in 
Nepal and the U.S. 
22% of women 
experience domestic 
violence. 4 
Heavy lifting  Yes Our study participants 
self-report carrying 
20-80kg regularly with 
a head strap. 
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Decreased estrogen  Yes Heavy work is 
performed during 
menstruation when 
estrogen levels are 
low.2 
Early return to work after delivery Yes Average was 45 days 
before returning to 
work in Nepal;   
maternity leave is 10-
42 days women may 
be less likely to do 
heavy manual work in 
the U.S.4  
Advanced age No POP develops at ages 
20-30 in Nepal, 1-2 
decades earlier than in 
the Western 
countries.4,5 
Obesity No Only 2.9% of Nepali 
adults are obese.9 
* Considered the most significant risk factor for POP in the western countries.  
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Abstract  
Background 
Pelvic floor trauma with vaginal delivery and heavy lifting, are thought to be risk 
factors for symptomatic pelvic organ prolapse (SPOP) in young Nepali women.1 The 
2011 Nepal Demographic and Health Survey found 6% of nulliparous women report 
SPOP, compared to 7% in the general population of Nepali women ages 15 – 49.2, 3 The 
average age of SPOP onset in Nepal is 27.3 In western countries SPOP is usually reported 
between the 4th and 6th decade of life.4, 5  
This study investigated the effect of increased intra-abdominal pressure (IAP) on 
pelvic organ descent during simulated lifting tasks in Nepali women across the menstrual 
cycle. The aims were to (i) calculate the descent of the pelvic floor organs during a 
simulated lifting task in a population of Nepali women, (ii) compare the descent between 
three stages of the menstrual cycle, and (iii) investigate the capacity of the pelvic floor 
muscles to resist pelvic organ descent by voluntarily contracting prior to performing the 
lifting task. We hypothesized that there was a relationship between heavy lifting during 
menstruation that could account for the unexpectedly high rates of young and nulliparous 
women with SPOP in Nepal possibly linked to their unique custom of Chhaupadi (ritual 
impurity during menstruation).6  
 
Methods 
22 asymptomatic Nepali women aged 18-30 years who regularly lift heavy loads 
were included in the study. Intra-abdominal pressure was measured intra-vaginally during 
both typical lifting tasks and simulated lifting tasks. Simulated tasks included: ballistic 
lifting, ramped lifting, ballistic lift with pre-contraction of the pelvic floor muscles, 
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cough, Valsalva, and pelvic floor contraction. Transperineal ultrasound (US) recorded 
displacement (mm) of the bladder base with simulated tasks during: menstruation, 
ovulation, and mid-luteal phase.    
 
Findings 
More pelvic floor displacement was found during menstruation than ovulation 
with simulated ballistic lifting (6·0 ± 1·6 vs 5·1 ±1·5, p = ·03). However, there was no 
significant difference in pelvic floor displacement with lifting when the pelvic muscles 
were pre-contracted.  
 
Interpretation 
The pelvic floor supportive tissues may be at increased risk for stretching and 
injury when lifting a heavy load during menstruation versus ovulation. Pre-contracting 
the pelvic muscles when lifting may demonstrate a protective effect.  
Key Words: prolapse, nulliparous, pelvic floor, lifting, menstrual cycle, laxity, 
compliance, elasticity, stiffness, chhaupadi. 
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Introduction:  
Background and Objectives  
Pelvic organ prolapse (POP) typically occurs when the passive and active pelvic 
support structures (e.g. connective tissue, ligaments and muscles) become weakened, 
stretched, or ruptured. Without support, the pelvic organs can descend under pressure into 
the vaginal canal and in advanced cases, protrude completely outside the introits.7 
Symptomatic pelvic organ prolapse (SPOP) occurs when pelvic organs become so 
displaced that pelvic function is affected.8 Women report a feeling of something coming 
out of their vagina, or uncomfortable pressure that can be very painful and even make 
sitting and other daily tasks difficult.  
Many women in Nepal who experience the devastating condition of SPOP do not 
seek help due to embarrassment, inability to pay for treatment, or lack of information 
regarding treatment options.9 Amnesty International deems SPOP a human rights issue in 
Nepal due to the serious impact SPOP has on the quality of life for these women.1, 10, 11 
The 2011 Nepal Demographic and Health Survey reported that in the general population, 
10% of Nepali women have POP. For women in their reproductive years, ages 15-49, 7% 
had POP, notably, 6% of nulliparous women in the same age category reported SPOP.2 
Furthermore, 14% of the women who developed SPOP did so in their teenage years. The 
mean age of onset is reported to be 27 years according to a study by the Institute of 
Medicine at Tribhuvan University Kathmandu.3 This is a sharp contrast to western 
women who typically develop SPOP after menopause.4, 12 Currently, the treatment 
options for SPOP in Nepal are vaginal hysterectomy, not an ideal outcome for young 
women of reproductive age, and pessary, which is less drastic but has poor patient 
compliance.13  
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Risk factors for SPOP include vaginal deliveries,14 poor pre- and post-natal care,10 
position at delivery10 and menopause,10  genetics and aberrant connective tissue.4, 15 
However, this does not account for the nearly identical rates of SPOP among nulliparous 
women of the same age. Previous studies have demonstrated a relationship between 
SPOP and weakness of supportive connective tissue and damaged pelvic floor muscles.16-
18 The influence of estradiol concentration on tissue laxity has been explored on the ACL 
in the knee and the plantar fascia of the foot across the menstrual cycle (MC)19-21 
However, there is little known about the effect of hormone concentrations on 
elasticity/compliance of the pelvic support mechanisms throughout the MC, and how it 
may influence the capacity of the pelvic floor to resist descent during demanding tasks 
which cause large increases in IAP.  
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Hormonal Effects of the Menstrual Cycle (MC)  
Some support structures of the pelvic organs have receptors for estradiol (and 
other gonadal hormones), and therefore may be affected by the cyclic changes in their 
concentration.16, 22 Decreased estradiol concentration has been shown to increase 
musculotendinous stiffness23 and decrease elasticity20  during menstruation.24  This has 
been extensively studied in the peripheral joints such as the knee and the ACL.20 The 
pelvic floor may also have cyclic changes in the tissue properties due to fluctuations in 
the estradiol concentrations. At early follicular phases, estradiol ranges from <20-145 
pg/mL and during ovulation it peaks at between 112-443 pg/mL.25  
Research in Context  
 
Evidence before this study 
We searched PubMed database with the terms ([pelvic organ prolapse], [Estradiol], 
[Menstrual Cycle], [intra-abdominal pressure] AND [pelvic floor dysfunction], and 
[Nepal]) with no date or language restrictions up to November 30, 2015 and searched the 
Nepal Health Ministry online reports and studies cited by them. No relevant studies 
making the connection between the menstrual cycle, increased intra abdominal pressure 
and pelvic floor dysfunction or prolapse were identified.   
 
Added value of this study 
To our knowledge this is the only study to address the issues of pelvic organ prolapse 
prospectively looking at the mechanical effects of the unique method of heavy lifting 
with a head strap and “doko” and its effect on the pelvic floor across the menstrual cycle.  
 
Implications of all the available evidence 
Results from this, and other studies looking at prevention of pelvic organ prolapse 
suggest that pre-contraction of the pelvic floor is an important technique when lifting 
heavy loads especially when menstruating. Globally 10% or more of woman will develop 
POP in their lifetime, and because Nepali women often develop symptoms early in their 
reproductive years prevention strategies are key to eliminating morbidity and the need for 
prohibitive surgical interventions.  
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Temperature Effects of the MC 
Tissue temperature has been shown to affect the mechanical properties of the 
ligaments.26 Basal body temperature changes across the MC; it is one half to one degree 
lower during the early follicular phase compared to the period after ovulation and 
throughout the luteal phase.27 Temperature increases have been shown to create laxity in 
other ligaments in the body when tested across the MC.20  
During menstruation, when estradiol and temperature are at the lowest points, the 
net effect is decreased elasticity and temperature, with increased stiffness, in connective 
tissue and musculotendinous tissues compared to ovulation (when estradiol and 
temperature are at their peak).20 
 
Cultural Effects on the MC 
The physiologic changes that occur throughout the MC may be particularly 
pertinent in Nepal. A typical work day for a woman living in rural Nepal would include 
many hours of preparing food, caring for children and livestock, as well as performing 
daily religious rituals. Her work load is considered to be 12-22% greater than that of the 
men.11 Menstruation is associated with ritual impurity. For this reason, women are not 
allowed to cook or perform religious tasks while menstruating, or touch a man, the 
practice is called “Chhaupadi”. It has been illegal in Nepal since 2005 but it is still widely 
adhered to throughout the country.6 Due to these restrictions women are limited to 
outdoor work, which often involves carrying heavy loads. This means they do a 
disproportionate amount of their heavier tasks during the time they are menstruating.   
Loads are carried with a cone-shaped basket on their back called a “doko” 
together with a head strap called a “namlo” which is worn over the forehead to support 
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the load. This method allows these women to carry very heavy loads long distances 
through steep and challenging terrain. Women with body weights between 40-60 kg 
reported they carried loads that were typically between 20-80 kg.   
The aims of this study were to (i) calculate the descent of the pelvic floor organs 
during a simulated lifting task in a population of Nepali women, (ii) compare the descent 
between three stages of the menstrual cycle, (iii) investigate the capacity of the pelvic 
floor muscles to resist pelvic organ descent by voluntarily contracting prior to performing 
the lifting task. 
 
Methods 
This was a prospective repeated measures study conducted using a convenience 
sample of 22 Nepali women. The study protocol was approved by the Institutional 
Review Board of Loma Linda University Health and by the Nepal Health Research 
Council. All participants were recruited using a local open advertisement. Prior to 
enrolment, prospective participants were screened by the researchers, a gynecologist and 
orthopedic surgeon to ensure they met the inclusion criteria. Participants were non-
pregnant women aged 18 to 30 years with regular menstrual cycles, who were 
asymptomatic for POP and engaged in activities that required regular use of a namol and 
doko for carrying loads. Exclusion criteria included history of pregnancy within the last 2 
years, pre menarche, peri- and post- menopausal, SPOP (Stage 2 or greater on Pelvic 
Organ Prolapse-Quantification System or POP-Q), irregular periods, use of an intra-
uterine device (IUD), and any spinal or orthopedic condition that would affect 
performance of the lifting tasks. Due to the use of Cidex (ASP, Irvine, California) as a 
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disinfecting agent for the Intravaginal Transducer (IVT) sensors, those with a history of 
bladder cancer were also excluded. 
The informed consent was read aloud in Nepali to the women because 40% of 
adult Nepali women have no education.2 A female nurse then conducted a standard 
questionnaire with each prospective participant to ensure that the participant fully 
understood the study prior to signing the informed consent. The general characteristics of 
the participants are in Table 2.  
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Table 2. Characteristics of the participants (N=22) 
 
Characteristic Mean (SD) No. (%) Median Range 
Age (year) 27·4 (3·6)     
Body mass index (kg/m2) 19·8 (3·2)     
Weight (kg)  lifted 19·8 (3·2)     
Number of pregnancies 1·7(1·0)     
Number of vaginal deliveries    2 (0-4) 
Number of days since 
carrying 
   2 (1-210) 
Ethnicity      
Newar  5 22·7   
Chhetri  4 18·2   
Tamang  5 22·7   
Brahman  8 36·4   
Religion      
Hindu  16 72·7   
Buddhist  6 27·3   
Rural  22 100   
Non-smokers  22 100   
No chronic pain  22 100   
No bladder cancer  22 100   
No ortho or neuro pathology  22 100   
No pain impairing function  22 100   
Constipation      
No  21 95·5   
Yes  1 4·5   
Menstrual pain      
No  16 72·7   
Yes  6 27·3   
Irregular Periods      
No  16 72·7   
Yes  6 27·3   
Pelvic organ prolapse       
Stage 0 20 90·9    
Stage 1 2 9·1    
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Each participant attended three separate sessions coinciding with the different 
phases of the menstrual cycle: within the first 4 days of the onset of menses (early 
follicular phase), within 24-48 hours of ovulation, and 6-10 days later at mid-luteal phase.  
Each participant was provided with a string of Cyclebeads® to assist with 
tracking their cycle days (CycleBeads® and Standard Days Method® Georgetown 
University) in addition to instructions and condoms to prevent becoming pregnant during 
the study. Furthermore, participants were provided with and educated on the use of the 
ClearBlue Advanced Ovulation tests (SPD Swiss Precision Diagnostics GmbH, Petit 
Lancy, Switzerland) to identify the time of ovulation.  
 
Procedures  
Intra-abdominal pressure was recorded using a validated intra-vaginal pressure 
transducer (IVT) (Department of Bioengineering, University of Utah, Salt Lake City, 
Utah)28 and body temperature was recorded by a fast-response sensor (TSD202A, 
BIOPAC Systems, Inc. Goleta, CA , USA). IAP and temperature data were recorded at 
1000 Hz using an analogue to digital converter (BioPac MP100, Goleta California) with 
24 bits of resolution. Data was stored digitally and analyzed later with Biopac 
Acknowledge 3·9·1 software. The temperature sensor was attached to the IVT with tape 
at the base of the IVT, and covered with a latex-free condom. Ultrasound data measuring 
pelvic floor displacement were collected using an ACUSON X300™ ultrasound system 
(Siemens Healthcare Global, Erlangen, Germany) and associated transducer (10027930 
4C1) which was placed on the perineum in the mid-sagittal plane.29 US data were 
recorded in video format (frame rate: 30 Hz) using the analogue to digital converter 
system described above. The ultrasound (US) recording was optimized to include the 
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urethral-vesical junction, the anorectal angle and the body of the pubic bone as a 
landmark.30  
Participants were instructed how to insert the IVT. The positioning was confirmed 
with US imaging. Following IVT insertion, resting IAP was recorded. The participant 
then performed three trial lifts of a doko basket loaded with a weight based on the 
participant's subjective tolerance to the load. Loads were approximately 40% or less of 
the participant’s body weight. Weights never exceeded 30 kg, the recommended 
guideline for commercial porters in Nepal.31 The mean load lifted by the participants was 
19·8 kg. The load was lifted off the ground to a full standing position using a head strap.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Starting (a) and ending (b) positions for the doko lift. 
 
Peak IAP pressure was averaged over three doko lifts and used to calculate a 
target for the simulated lifting tasks. The standing lift test was conducted only at one data 
collection session for each participant, and is illustrated in. Isometric simulation of lifts 
with transperineal US was conducted with participants positioned on an exam table in 
supine, approximately 20 cm from a wall. This enabled placement of the dominant foot 
a b 
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on the wall with 90 degrees of knee flexion; the left leg rested over the end of the table, 
illustrated in figure 6.  
Participants performed three repetitions of six different tasks in response to 
specific verbal instruction.32 Tasks included (i) a ballistic lift against a head strap, (ii) a 
slow ramped lift task performed over approximately 5-10 seconds toward the target IAP, 
(iii) an unprovoked cough, (iv) a Valsalva maneuver, (v) a Kegel or pelvic floor muscle 
contraction, and (vi) a ballistic head lift with Kegel pre- contraction. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Positioning of participants for ultrasound and pressure 
data collection for the six tasks. 
 
 
Participants 
Twenty-seven women completed the informed consent process and were enrolled 
into the study. However, only 22 were included in the final data analysis. Five were 
excluded for the following reasons: one had a death in the family and could not attend the 
data collection sessions; the second had a BMI over 30 and was chronically constipated, 
distorting her US images; the third started the study late and could only complete one 
session; the fourth had irregular cycles and did not ovulate or menstruate when expected; 
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the fifth was no longer living in a rural area and had been carrying water jars with her 
arms, not with a head strap.  
 
Data Analysis 
An experienced researcher measured the points on the US images at rest and at 
maximum displacement to determine the movement of the pelvic floor in millimeters.   
The reference points used were the ventral urethral vesicular junction30, in each task as it 
moved in relation to the mid- point of the pubic symphysis for each trial. Matlab 
(MathWorks, Natick, Massachusetts, USA) was used to derive a vector for the 
displacement which occurred. The peak-to-peak IAP change in pressure was recorded for 
each trial using AcqKnowledge, (BIOPAC Systems, Inc. Goleta, CA, USA). To control 
for pressure differences due to variance in efforts, the trials with the most similar 
pressures in each phase were selected for analysis.  
Data were analyzed using SPSS (IBM Corp. Released 2013. IBM SPSS Statistics 
for Windows, Version 22.0. Armonk, NY: IBM Corp). The general characteristics of the 
participants were summarized using means and standard deviations or median (min, max) 
for quantitative variables, and frequencies and relative frequencies for categorical 
variables. The normality of the variables was examined using the Kolmogorov-Smirnov 
and Shapiro-Wilk tests. A mixed 5 x 3 factorial analysis of variance (ANOVA) was used 
to assess changes in the displacement, temperature, and IAP of the various tasks (ballistic 
lift, ballistic lift with a pre contraction of the pelvic floor, unprovoked cough, Valsalva 
maneuver, and pelvic floor contraction) by menstrual phase (menstruation, ovulation and 
mid-luteal phase). Post hoc comparisons were conducted using a Bonferroni test. One-
way repeated measures ANOVA was used to compare mean IAP using the doko lift with 
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the IAP of the various tasks across all phases. The changes in displacement and IAP 
between the early follicular and ovulation phases for the same tasks were further 
compared using a paired t-test. The level of significance was set at p≤0.05. 
 
Results  
The temperature for all tasks was lowest during menstruation and highest during 
ovulation and remained elevated through the luteal phase, but no significant difference 
was found among menstrual phases, mean temperatures are reported in Table 3. 
 
Table 3. Mean (standard error) of temperature (ºC) by menstrual cycle (N=22) 
 Menstruation Ovulation Luteal P- value 
Temperature 36·8 (0·3) 37·3 (0·1) 37·2 (0·2) 0·16 
 
When comparing the displacement, there was a trend toward greater differences 
between ovulation and menstruation as they represent the extremes in estradiol levels, but 
it did not reach statistical significance because the variance in the luteal phase was too 
similar to the other phases. Therefore, to highlight the effects of estradiol we have 
reported the results from paired t-testing comparing the ovulation and menstruation 
phases only. 
Mean displacement of the pelvic floor varied from 3.4 mm (ballistic lift with 
pelvic floor pre-contraction) to 8.5 mm (Valsalva), and all means are reported in Table 4. 
Significantly less displacement was found during ovulation, except during Valsalva 
which was significantly more (p=.005). No significant difference was found between 
phases for the ballistic lift performed with pre-contraction (p value = 0.22). The PFM 
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demonstrated more displacement during menstruation than during ovulation (p = .05). 
These measurements were within the normal range of pelvic floor mobility found in other 
studies using translabial ultrasound.30 
 
Table 4. Mean (SE) displacement (mm) for each of 5 tasks by Menstrual phase (N=22) 
 
Task Ovulation Menstruation P values 
Ballistic*  5·1 (1·5) 6·0  (1·6) ·03 
Ballistic with PFM 3·4  (1·5) 3·9  (2·0) ·22 
Cough* 5·6  (1·5) 6·7  (2·3) ·02 
Valsalva* 8·5  (3·2) 6·0  (2·5) ·005 
PFM* -3·6  (1·3) -4·6  (1·6) ·05 
Abbreviations: SE, standard error; O, Ovulation; L, Luteal; M, Menstruation; BAL, 
Ballistic; BALPFM, Ballistic with pelvic floor contraction; PFM, Pelvic floor muscle 
contraction; a p values for the null hypothesis that there is no difference between the phases 
of the menstrual cycle. *significant change between ovulation and menstruation. 
 
Measurements of IAP changes are reported in Table 5. Mean IAP changes were not 
significantly different during ballistic lifts and ballistic lifts with PFM pre-contraction. 
However, a significant difference was found for cough and Valsalva between 
menstruation and ovulation. For all other tasks IAP was significantly different across the 
phases even after selection of trials with the most similar IAP. 
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Table 5. Mean (SE) IAP (cm2H2O) for each of the 5 tasks in 2 different test phases during 
the menstrual cycle (N=22) 
 
Task Ovulation Menstruation P values 
Ballistic  30·3 + 2·0 30·6 + 2·3 ·86 
Ballistic with PFM 29·9 + 3·3 33·6  + 4·3 ·27 
Cough 73·5  + 4·0 67·2  + 3·8 ·02 
Valsalva* 49·5  + 4·3 42·2  + 3·3 ·02 
PFM* 11·8  + 2·4 9·0 + 1·5 ·047 
Abbreviations: SE, standard error; O, Ovulation; L, Luteal; M, Menstruation; BAL, 
Ballistic; BALPFM, Ballistic with pelvic floor contraction; PFM, Pelvic floor muscle 
contraction; a p values for the null hypothesis that there is no difference among the phases 
of the MC for each task. *significant change between ovulation and menstruation. 
 
 
Table 6. Mean IAP for Doko lift as compared to mean of other tasks (N= 16) 
 
Task Mean (SE) p –valuea 
Bal 31·6 (2·1) 1·00 
BalPFM 33·3 (3·9) 1·00 
Cough 77·6 (3·9) <0·001 
Val 47·3 (4·9) 1·00 
PFM 9·0 (1·3) 0·001 
Doko lift 37·1 (4·3)  
Abbreviation: IAP, intra abdominal Pressure; SE, Standard error; a p value from post hoc 
testing pairwise comparisons between doko lift and other tasks. BAL, Ballistic; BALPFM, 
Ballistic with pelvic floor contraction; PFM, Pelvic floor muscle contraction; a p values 
for the null hypothesis that there is no difference between the IAP change in a simulated 
task and the IAP change in an actual doko lift.  
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Table 6 shows the simulated lifting tasks mean changes in IAP as compared to an actual 
doko lifting task. The mean IAP changes seen during ballistic lifts, ballistic lift with a 
pre-contraction of the pelvic floor, and Valsava were not significantly different from IAP 
changes experienced during an actual doko lift (p=1·0). However, the mean IAP change 
during cough and PFM was significantly different from the mean IAP changes using the 
doko lift (p <0·001 and p= 0·001, respectively, (see Table 6). These IAP levels were 
consistent with pressures found in women performing lifting tasks using IVT in other 
studies.33, 34   
 
Table 7. Pelvic Floor compliance mm/cmH2O comparison for each task at ovulation and at 
menstruation. 
 
Task Ovulation Menstruation 
Ballistic lift 0·17 0·2* 
Lift with PFM 0·11 0·12 
Cough 0·08** 0·1 
Valsalva 0·17 0·14 
PFM -0·3 -0·5 
Abbreviation: *Highest compliance, **lowest compliance in terms of downward 
displacement.  
 
Table 7 shows the complex interplay of tasks performed and tissue compliance in 
mm/cmH2O (compliance = change in volume/change in pressure).  The pelvic floor 
tissues displayed the highest compliance with ballistic lifting during menstruation 0·2 
mm/cmH2O and the least compliance with cough during ovulation 0·08 mm/cmH2O.  
These compliance levels were similar to those reported in studies looking at pelvic floor 
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displacement in cough and valslava in healthy nulliparious and primiparous woman.35, 36 
Of interest is that the compliance varies with task and menstrual cycle phase, with the 
highest compliance or least stiffness occurs with ballistic lifting during menstruation 
0.2mm/ cmH2O.   
 
Discussion  
Our use of the IVT with transperineal ultrasound capturing simultaneous IAP and 
pelvic floor displacement with simulated functional tasks was a novel approach to 
measuring changes in the biomechanics of the pelvic floor across the menstrual cycle. 
This instrumentation was valid and effective in the measurement of the variables. The 
data we collected was within the expected values for lifting activities.33 Other studies 
have not compared the dynamic reactions of the pelvic floor during functional lifting 
tasks across the menstrual phases. However, our study supports the hypothesis that there 
are significant changes in the mechanical properties of the musculotendinous tissues due 
to fluctuating estradiol. These findings were similar to studies of the Anterior Cruciate 
Ligament and plantar fascia where there was found to be an increased elasticity in 
ovulation as opposed to menstruation.20, 21  
There is limited consensus on the role of decreased estradiol as a risk factor for 
POP. Dietz argues that increased stiffness of the tissues with post-menopausal decreases 
in estradiol might even be protective against injury from stretch.4, 12 We found the 
opposite to be true. The pelvic floor moved consistently further in menstruation with 
lower pressures for ballistic activities than during ovulation. Thus, the pelvic floor 
displayed higher compliance during menstruation than during ovulation as is reported in 
Table 7. However, for the valsalva maneuver where the pressure changes were more 
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controlled and sustained (not ballistic) but IAP increases were higher the displacement 
was greater during ovulation than during menstruation. See Figure 7 for illustrations of 
the IAP graphs for each activity showing more abrupt IAP changes in coughing and 
ballistic activities as compared to valsalva.  
 
 
Figure 7. IAP Graphs for Each Activity. 
 
Key: A valsalva, B cough, C doko lift, D ballistic simulation, E ballistic 
simulation with pelvic floor precontraction, F pelvic floor contraction. Scale 
equals 20cmH2O. 
 
 
 
Ballistic lifting during menstruation may cause an increased potential for the 
development of POP. Because, there is greater tissue compliance in menstruation.  
Repetitive stretching of passive support tissues could logically lead to POP36.  
Pre-contracting the pelvic floor before ballistic activities such as lifting may 
compensate for the ballistic stretch and displacement that occurs with increased intra-
abdominal pressure.37 In our study pre-contraction of the pelvic floor muscles decreased 
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displacement by approximately 30% across all MC phases. Therefore exerting a 
protective effect even during menstruation that made the displacement variance across 
phases non-significant.  
 
Limitations  
Positioning for the trans-perineal ultrasound imaging is difficult during 
transitional movement. However, displacements of the pelvic floor have been noted to be 
significantly different in supine versus upright positions.38 This study attempted to match 
the mean peak IAP reached in an upright lift while the participant is lying in a modified 
hook position for the trans-perineal ultrasound imaging, with the lower extremities 
supported against a wall in a position similar to the squat used while lifting (modified 
hook/crook lying).  
The IVT created some shadowing in the US images but typically did not obscure 
the landmarks being measured. While the IVT may have affected the natural movement 
of the pelvic tissues, the effect would have been the same across all testing situations.  
 
Conclusion  
Epidemiological studies have been done to assess the risk factors for POP in the at 
risk native population of rural Nepali women who regularly perform tasks carrying a 
heavy doko. Although these studies identify heavy lifting as a risk factor, none of them 
assessed the mechanical effects of the doko lifting on the pelvic floor. Also no studies 
examined the impact of the MC as a common risk factor to parous and nulliparous 
women. Vaginal deliveries are assumed to be traumatic to the pelvic floor structures and 
the main risk factor in POP development, however, there is some evidence that rates of 
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POP are actually similar in nulliparous woman in Nepal.  Because Chhaupadi is practiced 
by all woman from the time of menarche it may to an additional risk factor for POP that 
has not been directly considered in the literature.  
Musculotendinous structures are known to be affected by the cyclic changes in 
estradiol. Although this relationship is complex and not fully understood, the mechanical 
effects on the pelvic floor can be predicted. This study shows that when estradiol is low 
the pelvic floor is more compliant (menstruation) and more elastic when estradiol peaks 
(ovulation). Further research is needed to confirm increased pelvic floor compliance 
during menstruation. 
Given the implications for the quality of life for millions of women in Nepal, 
development of a culturally sensitive, comprehensive prevention strategy for dealing with 
the issue of POP is imperative. Pelvic floor pre-contraction when lifting and avoiding 
heavy work during menstruation are promising preventative measures. Since both POP 
and surgical intervention have a major impact on cultural and socioeconomic factors, 
simple preventative measures maybe the key to a solution. Further studies are needed to 
confirm that education and preventive knowledge can in a practical way reduce the 
incidence of pelvic organ prolapse in rural Nepal.  
Recommendations should include; i) training in pre-contraction of the pelvic floor 
muscles when lifting, and other ballistic activities throughout MC and ii) avoidance of 
heavy ballistic lifting during menstruation. These could be key in prevention of early 
POP pathology and symptomatology. 
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CHAPTER 3  
BACKGROUND AND INSTRUMENTATION DETAILS 
 
Background on Nepal  
Nepal, an enchanting country nestled between China and India in South Asia, 
straddling the Himalayas.  Home to approximately 30 million people, it is culturally and 
geographically diverse, with 125 registered population groups, who speak about 123 
different languages and dialects.1 Nepal’s adult literacy rate 53% and life expectancy was 
67 years.1 The 2006 Status of Reproductive Health by the Institute of Medicine, 
Tribhuvan University, Kathmandu, Nepal found that 57% of Nepali women were 
employed in subsistence farming, selling what they can from their farm produce.  The 
majority (over 70%) of women had delivered their first baby as teenagers.  Ninety-one 
percent of births took place at home, either with traditional birth assistants or no 
assistance at all.2 The population of interest in this study is women of reproductive age 
living in Nepal.  
Pelvic organ prolapse (POP) is known to be a significant health problem in Nepal, 
with anywhere from 10 -25% of Nepali women affected.3 The Nepal Health 
Demographic Reports (2011) found that 10% of  women have POP, 7% of women  ages 
15-49 had POP, and 6% of even nulliparous women had symptomatic POP.4  Many social 
and economic factors are cited as being related to POP, such as early marriage, gender 
discrimination, and heavy lifting during pregnancy and after delivery.5  
POP can be debilitating for any woman, but perhaps even more so for women 
living in a developing country such as Nepal.  This condition may lead to social rejection, 
and make her work activities difficult and painful. Some studies assert that women are 
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aware of risks, such as working too soon after giving birth, but feel that they are not 
empowered to change their circumstances to reduce their risk.3 Many women in Nepal 
who experience POP do not seek help because they are embarrassed, poor, and do not 
know that POP is treatable.6 POP has a major impact on the quality of life for these 
women.7 
The issues of pelvic organ prolapse in Nepal have garnered international attention.  
Many NGOs as well as governmental organizations have been working to provide more 
accessible care and medical and surgical treatments to these women.8 Non-surgical 
options including pelvic muscle training and pessary fittings have also been studied.8  
There are no long term studies showing conservative measures to be effective in reducing 
cases of POP.  
Heavy lifting has been suspected as a risk factor for prolapse, though there is little 
known about the impact of functional lifting tasks on pelvic organ descent in women, 
some studies have measured increased IAP with lifting tasks.9 In Nepal, a unique method 
of lifting has long been used: a head strap known as a “namlo” is worn over the forehead 
extending back to the load, which is often carried in a cone shaped basket known as a 
“doko.” This method centers the load over the person’s center of gravity and allows very 
heavy loads to be carried long distances through topographically steep and challenging 
terrain.  The women interviewed for this study reported carrying 20-80kg in their dokos, 
many of them on a daily basis.  There is limited information on safe lifting loads when 
carrying a doko.  A 30kg limit was established for commercial porters in accordance with 
Nepali governmental guidelines and Porter Progress recommendations for porters using 
these lifting techniques.10   
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When lifting very heavy loads, Nepali women are observed to squat down, 
balance the doko against their backs with the head strap around their foreheads and 
encircle the load (basket) behind them; then with a quick ballistic forward movement of 
their torso, the woman will pull the doko off the ground, shift the weight over their center 
of gravity (lower lumbar spine) and stand up.  In preliminary investigation, peak muscle 
activation with EMG of abdominal muscles was observed at the moment of load 
acceptance and then decreased to nearly baseline once the load was in place and the 
woman was standing or walking.  Intra-abdominal pressure, though measured separately, 
followed the same pattern. The ballistic force needed to shift the load into position was 
targeted as the point at which to measure pelvic floor displacement.  There are no studies 
showing the normal IAP changes when a woman is lifting with a doko, and how this 
might affect her pelvic floor mobility.   
Another factor  that has not been addressed or investigated is the effect of the 
menstrual cycle on pelvic floor mobility.  Due to cultural traditions regarding 
menstruation, Nepali women  are not allowed to participate in religious rites or prepare 
food while menstruating.11  Since both  these activities take up a significant amount of a 
woman’s time in rural Nepal, it is thought that during her menstruation a woman should 
spend  more time performing  manual outdoor tasks.  This uneven distribution of heavy 
work across the menstrual cycle was verbally confirmed by women who attended the 
recruitment meetings for the study.  Therefore, in this study we sought to determine if 
heavy lifting, during menstruation was causing increased mobility in the pelvic floor.  If 
increased pelvic floor displacement was found to occur during menstruation, it might a 
factor in the higher-than-expected rates of POP seen among nulliparous women in Nepal.   
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Our study attempted to address these issues by measuring the increase in IAP with 
a typical doko lift, with a load determination algorithm starting with 40% or less of the 
body weight of the participant, loads were never to exceed 30kg and had to be easily 
tolerated by the participant.   
 
Research Venue 
The study venue was Scheer Memorial Hospital, in Banepa, Nepal. This is an 
Adventist mission hospital that has been in operation for over 50 years under the sanction 
of the former kings of Nepal. One of the oldest and most respected hospitals in eastern 
Nepal, it is located about 12 miles southeast of Kathmandu, the capital city. Scheer has 
150 beds, offers 24 hour emergency care, as well as surgical, pediatric, internal medicine, 
orthopedic, and OB/GYN specialties. Diagnostic imaging, laboratory and pharmacy 
services are also available. There is a nursing school on campus that graduates 20 
bachelor-level nurses each year. 
The majority of the patients and staff live in small villages surrounding the 
hospital. Many of the villagers live a mostly subsistence farming lifestyle, which requires 
that every family member be involved, often in heavy manual labor. Women carry much 
of the load, usually caring for the garden and livestock. All these factors made Scheer 
Memorial Hospital an ideal location for recruiting participants and performing data 
collection. 
Scheer Memorial Hospital has long been instrumental in community health 
education. This tradition is continued with regular community educational events 
produced by the School of Nursing, international teams of medical specialists, and the 
hospital staff on a regular basis. This study made a significant contribution by providing 
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an open invitation to community women to participate in an informational meeting 
conducted prior to recruitment activities. An open invitation was posted around the 
hospital and passed by word of mouth. The meeting involved providing cycle beads and 
condoms, with training in their use, to all attendees. Also provided were appropriate 
levels of training on POP prevention and basic reproductive health information related to 
the study. All supplies including condoms, cycle beads and ovulation tests, remaining 
after the study was completed were donated to the OB/GYN clinic to be provided to local 
women visiting the clinic.  Plans are underway to disseminate the information within 
Nepal to healthcare providers, community focus groups, and local health aids.  
Scheer Memorial was well situated with access to the medical equipment needed 
to conduct the study, licensed physicians to conduct the clinical screening, and easily 
accessible to the rural population of interest in the study.  Scheer Memorial Hospital 
strongly supports excellence in service, education, and research.  The researchers were 
able to brief the physicians in the hospital’s strong orthopedics and OB/GYN programs, 
who screened the participants, on the study in detail with provide lists of criteria for the 
screening process. Prior to enrollment, each participant was required to submit a form 
showing they had been screened by both physicians and specialists.   
Staff at the hospital are bilingual in Nepali and English and were well qualified 
and experienced in translating medical and clinical information.  For our study, we used 
nurses who had been the researcher’s anatomy students at the nursing school.  All 
participating nurses were female, with an excellent grasp of the English language and 
fluent in Nepali.  All the staff who assisted in the study were familiar with universal 
precautions when handling objects exposed to body fluids, and were further trained in the 
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disinfection process for the ultrasound probes, IVT, and wiring used in the study. 
Translators ensured that participants in the study were fully informed of the study 
procedures, risks, and objectives before they signed the informed consent forms. 
 
Instrumentation Rationale  
We sought to determine if functional lifting tasks would significantly displace the 
pelvic floor and how the various menstrual phases effect that mobility. In order to 
accomplish this, we needed to match the same IAP achieved in typical lifting tasks with 
the participant in a supine position to accommodate the transperineal US probe while 
simulating an isometric lift with a head strap.  Positioning affects the strength of the 
pelvic floor and the IAP.  In supine, the pelvic floor is stronger and typically IAP lower 
than when standing.12  To measure pelvic floor mobility in standing would be logistically 
difficult with either transperineal or transabdominal US, as positioning the probe while 
the participant was moving through a natural lifting position would be very difficult.  
Probe orientation and stability are crucial to getting a clear image. To minimize the 
changes in pelvic floor mobility from standing to sitting, we were able to match the 
average peak IAP achieved in standing while performing the task in supine.    
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Table 8. Mean IAP for Doko lift as compared to mean of other tasks (N= 16) 
 
Task Mean (SE) p –valuea 
Bal 31·6 (2·1) 1·00 
BalPFM 33·3 (3·9) 1·00 
Cough 77·6 (3·9) <0·001 
Val 47·3 (4·9) 1·00 
PFM 9·0 (1·3) 0·001 
Doko lift 37·1 (4·3)  
Abbreviation: IAP, intra-abdominal pressure; SE, Standard error; a p value from post hoc 
testing pairwise comparisons between doko lift and other tasks. 
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Table 8 shows there is no significant difference in the IAP changes between 
simulated lifting tasks and the actual doko lifts, p = 1.00.   
Other factors which may affect the mobility of the pelvic floor are the 
biomechanics of the pelvic floor and synergy motor patterns active in lifting. Gluteal 
muscles, which are active during hip movement and provide stability during lifting, have 
a synergistic effect on the pelvic floor.13 With participants in supine while we measured 
pelvic floor mobility, the synergistic effects of the gluteal muscles on the pelvic floor 
may not have been as active in our simulated task as in the functional upright lift.  As 
expected, an activated pelvic floor muscle was shown to decrease pelvic floor 
displacement in our study.14 However, since our aim was to measure the effect of the 
menstrual cycle on pelvic floor mobility, the positioning for US imaging and task 
performance were identical at each test session for each menstrual phase. Our study 
cannot address the effects the gluteal activation in an actual lift may differ from that in a 
simulated lift and how this may alter pelvic floor functional strength.13 
The ultrasound used in the research project was the ACUSON X300™ ultrasound 
system (Siemens Healthcare Global, Erlangen, Germany) which was set up and 
connected to a laptop computer and video capture synched with the BIOPAC 
measurements.  The probe used was the CH4-1 curved linear array, covered with a latex-
free condom during transperineal US.  After viewing the video, the trials with the most 
similar pressures were selected, then the still frames of the rest period before activity and 
peak displacement were saved for measurement in a custom Matlab (MathWorks, Natick, 
Massachusetts, USA) program.  The ventral urethralvesicular junction was identified in 
each image and displacement was calculated by comparing the two images using a 
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relative coordinate system based on the center of the pubic bone. Trials selected for 
statistical analysis were those with the most closely matched IAP changes for each 
subject. 
The intravaginal pressure transducer (IVT) used in our study was developed at the 
University of Utah for studies that allowed wireless recordings of IAP over extended 
periods of time while performing a variety of tasks.  It has been validated and found to be 
more reliable and consistent in measurements compared with rectal sensors. The IVT was 
designed to be comfortable enough that women would not notice its presence when 
correctly inserted.15,16 We chose this sensor because it was more reliable than the rectal 
balloon type sensors, and much more comfortable and incurred less risk than a 
nasogastric sensor.  The IVT seemingly did not alter pelvic floor compliance since we 
were able to demonstrate similar values compared to other studies.  Our overall descent 
of the pelvic floor may have been limited, as the values we obtained were on the lower 
end of the normal range found by Deitz.17 However, since we were looking for 
differences across the menstrual cycle as long as IVT use was consistent across the cycle 
it should not have impeded our ability to detect changes across the cycle.  
Each participant’s baseline IAP, measured while standing and lifting in the lab, 
showed similar IAP levels to those found in studies of Western women for lifting and 
carrying tasks while walking.  The maximum IAP for our study participants in all tasks 
typically ranged from 45-95cmH2O, other studies showed ranges of 55-77 for Western-
style carrying techniques.18 An average compliance for the pelvic floor of 
0.083mm/cmH2O2 for cough in nulliparious women and 0.167mm/cmH2O2 for healthy 
primiparous women.14,19 By measuring both IAP and displacement of the pelvic floor we 
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could reliably calculate the compliance of the tissues across the menstrual cycle. Other 
studies did not control for the menstrual phase.  
The ballistic nature of some tasks seems to have altered the compliance of the tissues 
across the menstrual cycle (see Table 9).  Cough, which causes a quick spike in IAP, has 
a lower compliance than a task with a slightly more gradual change in IAP increase such 
as a Valsalva.19  
 
Table 9. Showing average compliance for each task at ovulation and menstruation in 
mm/cmH2O.  N=22 
 
Task O M 
BAL  0.17 0.2* 
BALPFM 0.11 0.12 
Cough  0.08** 0.1 
VAL 0.17 0.14 
PFM  -0.3 -0.5 
Abbreviations: O, Ovulation; L, Luteal; M, Menstruation; BAL, Ballistic; BALPFM, 
Ballistic with pelvic floor contraction; VAL, Valsalva; PFM, Pelvic floor muscle 
contraction; *Highest compliance across tasks and menstrual phases.  **This nearly the 
same as mean compliance in healthy nulliparous woman 0.083 mm/cmH2O (14).  
 
Estimating Relative Estradiol Levels  
Levels of the primary marker of the menstrual phase, estradiol, increased around 
ovulation and stayed elevated through the luteal phase and declined during the early 
follicular phase (see below).20  
• Estradiol levels in Follicular phase: <20-145 pg/mL (184-532 pmol/L)  
• estradiol levels at Ovulation: 112-443 pg/mL (411-1,626 pmol/L) 
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• Estradiol levels in luteal phase: <20-241 pg/mL (184-885 pmol/L) 
The literature shows that after menopause, decreased estradiol levels as low as 0-
40 pg/mL have been linked to POP, because pelvic floor structures become weaker when 
estradiol levels are lower 21.  However, there are no studies on changes in the pelvic floor 
when estradiol levels fluctuate during the menstrual cycle, which at menstruation can 
decrease to post-menopausal levels <20-145 pg/mL.20,22  Because hormonal changes may 
be a factor affecting tissue properties of the pelvic floor, the study repeated testing 
measures in each of the major phases of the menstrual cycle.  Though there is no 
consensus about which phases have an inherently higher risk of tissue injury, some 
studies have shown ovulation to increase risk due to higher estradiol levels, which may 
promote ligament laxity. Park found an increased laxity and decreased stiffness in the 
knee joint at ovulation.22 The supportive structures of the pelvic organs have receptors for 
estradiol (and other gonadal hormones), and may be affected by the cyclic changes in 
these hormones.23 Lower estradiol levels has been shown to increase musculotendinous 
stiffness24 and decreased elasticity25 during menstruation.26  
Is increased stiffness a risk or a benefit?  Dietz asserts that increased post-
menopausal stiffness may be protective against POP, with resulting vaginal stenosis 
instead of prolapse. 27 The purpose of this study was to evaluate the relationship between 
estradiol fluctuations in normal menstrual cycles and the response of pelvic floor support 
tissues during functional tasks. This could have implications not only for Nepali women, 
but for all women who engage in heavy manual labor or athletic activities during 
potentially higher risk phases of their menstrual cycles. 
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Testing blood levels of hormones is outside the scope of this study. However, if 
significant differences in pelvic floor displacement with increased IAP are found between 
the various menstrual phases, it may lead to further investigation, including studies of 
blood levels of relaxin and estradiol. 
This study marked the menstrual cycle from the first day of menses to the LH 
surge as the follicular phase. The LH surge marked ovulation as measured by the 
Clearblue Advanced Digital Ovulation Test. The luteal phase was marked from ovulation 
to the beginning of the next cycle. Data collection took place three times during this 
cycle: 
1. Within the first 4 days of menses (early follicular phase) 
2. Within 24-48 hours of the peak fertility indication 
3. 6-10 days after the LH surge (Robinson & Ellis, 2007). 
The at-risk population of Nepali woman is about 53% literate.1 Thus we needed a 
home urinalysis test that would be easily interpreted by even illiterate women and non-
English speakers. The Clearblue Advanced Digital Ovulation test (SPD Swiss Precision 
Diagnostics GmbH, Petit Lancy, Switzerland) was chosen because it is easy to see when 
ovulation has occurred within 4 days, based on the “smiley face” symbol rather than 
another symbol which might be hard to explain to women who may or may not be 
literate. Participants were taught how to use the advanced Clearblue ovulation tests using 
the teach-back method so they would be able to identify the day they should come in for 
testing at the time of ovulation.  They were also given a string of cycle beads 
(CycleBeads® and Standard Days Method® Georgetown University) to track their cycles 
and provided with instructions for their use. Most participants knew exactly how many 
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days it had been since their last period and were able to identify the day in the cycle they 
were currently on, so we were able to immediately begin testing with women in the 
menstrual phase and luteal phases.  In order to perform accurate testing and identify the 
actual time of ovulation all the participants were required to use the ovulation urinalysis 
tests from the 6th or 7th day in their cycle. The cycles of each participant were tracked by 
the researchers and the participants were reminded by phone to do their home urinalysis 
testing when appropriate. The cycle beads were chosen because they have been used in 
developing countries and illiterate populations to help women track their fertility and 
menstrual cycles effectively in other studies.28  The women in our study were able to 
track their cycles effectively and we are fairly certain we tested at the correct times since 
the mean basal body temperature was elevated in ovulation, lower during the luteal 
phase, and lowest during the menstrual phase testing sessions.  
 
Measuring Temperature 
Elastic properties of tissues are altered by temperature and loading rate. The 
temperature of a tissue has been shown to effect its mechanical properties.29,30 Core body 
temperature is normally between 36-37.5°C.31 Temperature is  also affected by the 
menstrual cycle,32 with the basal body temperature one-half to one degree lower during 
the early follicular phase than after ovulation and throughout the luteal phase.  
Temperature changes have been shown to affect the performance of other ligaments in 
the body when tested across the menstrual cycle.33 
To measure temperature we taped a fast-response sensor (TSD202A, BIOPAC 
Systems, Inc. Goleta, CA USA) to the base of the IVT.  Both sensors then were inserted 
into a latex-free condom and after careful instruction, the participant was asked to insert 
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the instrument into her vagina, high enough that the device was resting above the pelvic 
floor muscles, was comfortable to the participant, and stayed in place.  
During menstruation, when estradiol and temperature are at the lowest points, the 
net effect is decreased elasticity and temperature, with increased stiffness in the pelvic 
structures, versus at ovulation, when estradiol and temperature are at their peak.34 In this 
study, we measured temperature changes by recording continuous readings intra-
vaginally with a sensor attached to the IVT (Department of Bioengineering, University of 
Utah, Salt Lake City, Utah).   
 
Measuring Pelvic Floor Mobility with Transperineal Ultrasound (US) 
Ultrasound (US) has been shown to be a valid tool for measurement of the pelvic 
floor and organ displacement or movement.35-39 Various methods of US imagining have 
been reviewed and addressed in the literature. Transperineal US was chosen for this study 
as a way to visualize pelvic floor structures and measure transitional movements. 
Suprapubic US and transabdominal ultrasound (TAUS) measurement techniques were 
also explored; however, suprapubic TAUS would be difficult since the abdominal wall is 
not stationary during activity and breathing.36 Consistent imaging strategies were used 
and scripted instructions for all test activities were followed to get the most reliable data 
possible. When compared to other methods, US has been considered a reliable method of 
visualization of pelvic floor morphology.40,41 The movement of the urethralvesicular 
junction with changes in IAP were measured with the subject in a modified crook lying 
position, since positioning for transperineal ultrasound imaging is difficult during 
squatting to standing movement. Because displacements of the pelvic floor have been 
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noted to be significantly different in supine versus upright positions.12 This study 
attempted to match the mean peak IAP reached in an upright lift while the subject is lying 
in a modified crook position for the transperineal ultrasound imaging, with the lower 
extremities supported against a wall in a position relative to each other and similar to the 
squat used while lifting the actual doko.  Normal mobility of the pelvic floor measured 
with translabial ultrasound (Figure 8) was shown to be widely varied from 1.2 – 40.2 
mm.17 Perhaps much of this variability was due to changes in the biomechanical 
properties of the tissue changes induced by fluctuations of estradiol across the menstrual 
phase as Dietz study did not control for phase of the menstrual cycle.   
 
 
Figure 8. Pelvic Floor US image used in the study. 
 
 
Measurement of Intra-abdominal Pressure (IAP) 
Intra-abdominal pressure (IAP) rises during dynamic lifting activities;42,43 
therefore, the use of continuous monitoring of the IAP was important to this study. In 
order to identify when peak IAP occurs with isometric simulation of head-bearing lifting 
(ISHBL), an intravaginal pressure transducer IVT (Figure 9) was used.15,44 This 
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transducer was developed and approved for use in research done by the University of 
Utah Health Sciences Center Institutional Review Board.15 The IVT is similar in size and 
shape to an O.B. brand tampon. Placement was done by the subject and then confirmed 
with transperineal US. The sensor was reused, sterilized, and placed inside a condom for 
each trial. Subjects have reported it to be comfortable and that the IVT did not impair 
movement.15 Normal IAP for women performing functional tasks was found to be 40-80 
cm H20.9,18  In our study, when we measured the peak-to-peak pressure changes and 
increase over resting baseline pressure with functional tasks, these pressure increases 
were typically between 20-100 cmH2O.  This sensor transmits the IAP as measured in the 
upper vagina to the BIOPAC to a computer monitor for real-time analysis. The sensor 
was used to track IAP during lifting tasks, ISHBL, and other tasks used for 
standardization in a modified crook lying position during transperineal US imaging.   
Calibrated and tested sensors were alternately used in the data collection. Sterilization 
was done by covering the sensors in latex-free condoms while in use;  between uses the 
sensors and wires were soaked with Cidex (ASP, Irvine, California)  per manufacturer 
instructions and rinsed in sterile saline prior to the next use. This is the protocol currently 
used in the operation theater at Scheer Memorial Hospital and also meets or exceeds the 
JHACO guidelines and manufactures recommendations for sterilization of equipment that 
is reused with multiple patients.  
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Figure 9. Photo of the IVT sensor in hand for size reference. 
 
 
 
 
Explanation of Findings   
The pelvic floor is at significant risk of damage in vaginal delivery, and rates of 
injury may be higher in deliveries using forceps.45 However, in Nepal, where most births 
take place at home, the POP rates are very similar to those in Western countries, although 
reports of symptomatic POP occur about a decade or so earlier.  Also nulliparous women 
in Nepal have relatively high rates of POP as well, since 10-20% of women have fascial 
defects even without vaginal deliveries.14 These defects in nulliparous women and the 
levator ani tears in vaginal deliveries for parous women impair the active support 
structures of the pelvic floor and put more pressure on the passive support structures. 
Perhaps the increased compliance that occurs in the early follicular phase and 
accompanies menstruation, superimposed on a lifestyle which requires heavy lifting 
during this time, plays a role in gradually stretching out the passive support structures and 
defects sooner for women in Nepal.  
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Strategies that may decrease the repetitive trauma to the pelvic floor and prevent 
the early onset of POP in at-risk women include; 1) pre-contracting the pelvic floor 
muscles when lifting, coughing, sneezing and laughing 2) avoiding heavy and ballistic 
lifting while menstruating  3) avoiding ballistic lifting strategies.  
 
Implications for Further Study 
Contributing factors we were not able to control for were muscle activation 
patterns and synergistic behaviors of muscles depending on the lifting strategies. Gluteal 
muscles have a synergistic effect on the pelvic floor muscles in men.13 In addition, pelvic 
tilting can increase or decrease stretch on the pelvic muscles; this was not controlled for 
and may have an effect on the strength of contraction of the muscles.  
Some research shows relaxin levels increase during menstruation, but we were 
able to control for fluctuations in relaxin in our study.23,46  Further study needs to be done 
to determine if the changes in pelvic floor compliance are due to relaxin and estradiol and 
how or if they affect one another.  
We were not able to control for parity and instead excluded women with stage 2 
or more on a POP-Q testing.  We were able to derive virtually the same compliance ratios 
in our mixed group of women with parity ranging from 0-4 as in other studies, looking at 
cough-induced displacement of the pelvic floor in nulliparous women.17 Further 
investigation needs to be done on the true effects of parity versus pelvic trauma that may 
be increasing the risks of developing POP in women. 
To confirm and clarify our findings, further research is needed on the complex 
interplay of cyclic hormone physiology on tissue compliance and how this effects the 
biomechanics of the pelvic floor. Future studies should be done to fully verify normal 
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ranges for IAP and pelvic floor displacement incurred with head bearing lifting as it is 
done in at-risk populations.  Head bearing lifting techniques may present a unique pattern 
of muscle synergy and firing patterns that merits detailed analysis. As more of this 
information is better understood we may be able identify the factors that are putting non-
symptomatic women at risk of developing SPOP.  Ideally we will be able to establish 
guidelines for lifting strategies which will allow women to avoid SPOP.   
 
 
66 
References  
1. Statistics CIACBo. The World Factbook 2016 [11/21/2016]. Available from: 
https://www.cia.gov/library/publications/the-world-factbook/geos/np.html. 
2. Institute of Medicine Tribhvan University Kathmandu N. A reproductive morbidity 
report on clinic based survey 2006; Status of Reproductive Morbidities in Nepal. 
report Submitted to United Nations Population Fund (UNFPA) Pulchowk, Lalitpur, 
Nepal. 2006 2006. 
3. Radl CM, Rajwar R, Aro AR. Uterine prolapse prevention in Eastern Nepal: the 
perspectives of women and health care professionals. Int J Womens Health. 
2012;4:373-82. 
4. Population Division Ministry of Health and Population NE, ICF International. Nepal 
Demographic and Health Survey 2011. Population Division Ministry of Health and 
Population Government of Nepal, Population; 2012. 
5. International A. Unnecessary Burden Gender Discrimination and Uterine Prolapse in 
Nepal. Amnesty International February 2014. 2014;Index:ASA31/001/2014. 
6. Shrestha B, Onta S, Choulagai B, Poudyal A, Pahari DP, Uprety A, et al. Women's 
experiences and health care-seeking practices in relation to uterine prolapse in a hill 
district of Nepal. BMC Womens Health. 2014;14:20. 
7. Lien YS, Chen GD, Ng SC. Prevalence of and risk factors for pelvic organ prolapse 
and lower urinary tract symptoms among women in rural Nepal. Int J Gynaecol 
Obstet. 2012;119(2):185-8. 
8. Fitchett JR, Bhatta S, Sherpa TY, Malla BS, EJ AF, Samen A, et al. Non-surgical 
interventions for pelvic organ prolapse in rural Nepal: a prospective monitoring and 
evaluation study. JRSM Open. 2015;6(12):2054270415608117. 
9. Coleman TJ, Hamad NM, Shaw JM, Egger MJ, Hsu Y, Hitchcock R, et al. Effects of 
walking speeds and carrying techniques on intra-abdominal pressure in women. Int 
Urogynecol J. 2015;26(7):967-74. 
10. UK PP. Trekking Guidelines UK Registered Charity No. 1112943; 2016 [updated 
2016. Available from: http://www.portersprogressuk.org/advice-for-
trekkers/trekking-guidelines/. 
11. Haviland C. Nepal's 'confinedwomen' want change. BBC News; 2009/03/04 
23:59:19 GMT. 
12. Frawley HC, Galea MP, Phillips BA, Sherburn M, Bo K. Effect of test position on 
pelvic floor muscle assessment. Int Urogynecol J Pelvic Floor Dysfunct. 
2006;17(4):365-71. 
 
 
67 
13. Asavasopon S, Rana M, Kirages DJ, Yani MS, Fisher BE, Hwang DH, et al. Cortical 
activation associated with muscle synergies of the human male pelvic floor. J 
Neurosci. 2014;34(41):13811-8. 
14. Ashton-Miller JA, DeLancey JO. Functional anatomy of the female pelvic floor. 
Ann N Y Acad Sci. 2007;1101:266-96. 
15. Coleman TJ, Thomsen JC, Maass SD, Hsu Y, Nygaard IE, Hitchcock RW. 
Development of a wireless intra-vaginal transducer for monitoring intra-abdominal 
pressure in women. Biomed Microdevices. 2012;14(2):347-55. 
16. Egger MJ, Hamad NM, Hitchcock RW, Coleman TJ, Shaw JM, Hsu Y, et al. 
Reproducibility of intra-abdominal pressure measured during physical activities via 
a wireless vaginal transducer. Female Pelvic Med Reconstr Surg. 2015;21(3):164-9. 
17. Dietz HP, Eldridge A, Grace M, Clarke B. Pelvic organ descent in young nulligravid 
women. Am J Obstet Gynecol. 2004;191(1):95-9. 
18. Coleman TJ, Nygaard IE, Holder DN, Egger MJ, Hitchcock R. Intra-abdominal 
pressure during Pilates: unlikely to cause pelvic floor harm. Int Urogynecol J. 
2015;26(8):1123-30. 
19. Howard D, Miller JM, Delancey JO, Ashton-Miller JA. Differential effects of cough, 
valsalva, and continence status on vesical neck movement. Obstet Gynecol. 
2000;95(4):535-40. 
20. Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R. 
Establishment of detailed reference values for luteinizing hormone, follicle 
stimulating hormone, estradiol, and progesterone during different phases of the 
menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med. 
2006;44(7):883-7. 
21. Rizk DE, Fahim MA. Ageing of the female pelvic floor: towards treatment a la carte 
of the "geripause". Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(4):455-8. 
22. Park SK, Stefanyshyn DJ, Loitz-Ramage B, Hart DA, Ronsky JL. Changing 
hormone levels during the menstrual cycle affect knee laxity and stiffness in healthy 
female subjects. Am J Sports Med. 2009;37(3):588-98. 
23. Dietrich W, Elenskaia K, Obermayr E, Horvat R, Mayerhofer K, Umek W, et al. 
Relaxin and gonadal steroid receptors in uterosacral ligaments of women with and 
without pelvic organ prolapse. Int Urogynecol J. 2012;23(4):495-500. 
24. Bell DR, Blackburn JT, Norcorss MF, Ondrak KS, Hudson JD, Hackney AC, et al. 
Estrogen and muscle stiffness have a negative relationship in females. Knee Surg 
Sports Traumatol Arthrosc. 2012;20(2):361-7. 
 
 
68 
25. Lee H, Petrofsky JS, Daher N, Berk L, Laymon M. Differences in anterior cruciate 
ligament elasticity and force for knee flexion in women: oral contraceptive users 
versus non-oral contraceptive users. Eur J Appl Physiol. 2014;114(2):285-94. 
26. Eiling E, Bryant AL, Petersen W, Murphy A, Hohmann E. Effects of menstrual-
cycle hormone fluctuations on musculotendinous stiffness and knee joint laxity. 
Knee Surg Sports Traumatol Arthrosc. 2007;15(2):126-32. 
27. Dietz HP. The aetiology of prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 
2008;19(10):1323-9. 
28. Lundgren R, Sinai I, Jha P, Mukabatsinda M, Sacieta L, Leon FR. Assessing the 
effect of introducing a new method into family planning programs in India, Peru, 
and Rwanda. Reprod Health. 2012;9:17. 
29. Petrofsky JS, Laymon M, Lee H. Effect of heat and cold on tendon flexibility and 
force to flex the human knee. Med Sci Monit. 2013;19:661-7. 
30. Petrofsky J, Al Malty A, Suh HJ. Isometric endurance, body and skin temperature 
and limb and skin blood flow during the menstrual cycle. Med Sci Monit. 
2007;13(3):CR111-7. 
31. Petrofsky JS, Laymon M. Heat transfer to deep tissue: the effect of body fat and 
heating modality. J Med Eng Technol. 2009;33(5):337-48. 
32. Baker FC, Waner JI, Vieira EF, Taylor SR, Driver HS, Mitchell D. Sleep and 24 
hour body temperatures: a comparison in young men, naturally cycling women and 
women taking hormonal contraceptives. J Physiol. 2001;530(Pt 3):565-74. 
33. Lee H, Petrofsky JS, Daher N, Berk L, Laymon M, Khowailed IA. Anterior cruciate 
ligament elasticity and force for flexion during the menstrual cycle. Med Sci Monit. 
2013;19:1080-8. 
34. Bertone-Johnson ER, Ronnenberg AG, Houghton SC, Nobles C, Zagarins SE, 
Takashima-Uebelhoer BB, et al. Association of inflammation markers with 
menstrual symptom severity and premenstrual syndrome in young women. Hum 
Reprod. 2014;29(9):1987-94. 
35. Ferreira PH, Ferreira ML, Nascimento DP, Pinto RZ, Franco MR, Hodges PW. 
Discriminative and reliability analyses of ultrasound measurement of abdominal 
muscles recruitment. Man Ther. 2011;16(5):463-9. 
36. Hodges PW. Ultrasound imaging in rehabilitation: just a fad? J Orthop Sports Phys 
Ther. 2005;35(6):333-7. 
 
 
69 
37. Junginger B, Baessler K, Sapsford R, Hodges PW. Effect of abdominal and pelvic 
floor tasks on muscle activity, abdominal pressure and bladder neck. Int Urogynecol 
J. 2010;21(1):69-77. 
38. Stafford RE, Ashton-Miller JA, Constantinou CE, Hodges PW. Novel insight into 
the dynamics of male pelvic floor contractions through transperineal ultrasound 
imaging. J Urol. 2012;188(4):1224-30. 
39. Whittaker JL, Thompson JA, Teyhen DS, Hodges P. Rehabilitative ultrasound 
imaging of pelvic floor muscle function. J Orthop Sports Phys Ther. 2007;37(8):487-
98. 
40. Dietz HP. Why pelvic floor surgeons should utilize ultrasound imaging. Ultrasound 
Obstet Gynecol. 2006;28(5):629-34. 
41. Lone FW, Thakar R, Sultan AH, Stankiewicz A. Accuracy of assessing Pelvic Organ 
Prolapse Quantification points using dynamic 2D transperineal ultrasound in women 
with pelvic organ prolapse. Int Urogynecol J. 2012;23(11):1555-60. 
42. Gerten KA, Richter HE, Wheeler TL, 2nd, Pair LS, Burgio KL, Redden DT, et al. 
Intraabdominal pressure changes associated with lifting: implications for 
postoperative activity restrictions. Am J Obstet Gynecol. 2008;198(3):306 e1-5. 
43. Iqbal A, Haider M, Stadlhuber RJ, Karu A, Corkill S, Filipi CJ. A study of 
intragastric and intravesicular pressure changes during rest, coughing, weight lifting, 
retching, and vomiting. Surg Endosc. 2008;22(12):2571-5. 
44. Hsu Y, Coleman TJ, Hitchcock RW, Heintz K, Shaw JM, Nygaard IE. Clinical 
evaluation of a wireless intra-vaginal pressure transducer. Int Urogynecol J. 
2012;23(12):1741-7. 
45. Dietz HP. Pelvic floor trauma following vaginal delivery. Curr Opin Obstet Gynecol. 
2006;18(5):528-37. 
46. Dragoo JL, Castillo TN, Korotkova TA, Kennedy AC, Kim HJ, Stewart DR. Trends 
in serum relaxin concentration among elite collegiate female athletes. Int J Womens 
Health. 2011;3:19-24. 
  
 
 
70 
APPENDIX A 
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“Displacement of the Pelvic Floor with Isometric Simulation of Head Bearing 
Lifting at 3 Crucial Points in the Menstrual Cycle” 
 
Before you can be part of the project, we need to be sure it is safe for you to lift 
heavy loads and that you are healthy and not pregnant.  To find out we will have 
you answer a list of questions about your health and how hard you work.  You 
will be asked three questions by another person after the researcher has 
explained this paper to you.  This is to see if you understood what you have been 
told about the study.  If you understand and want to participate then you will get 
two free routine medical checkups. One at the woman’s doctor clinic and one at 
the bone doctor’s clinic. They will  check you very carefully to be sure you are not 
at risk of getting hurt by lifting in the study and that your uterus is not falling a 
little bit already.  They will also do a pregnancy test to be sure you are not 
pregnant before you can be in the study. If the doctors can find no problems you 
will be told when and where to come for the study.  Below is a list of the things 
you will do if you participate in the study:  
 
 First you will be taught how to do a special test that will tell you if your body is 
ready to get pregnant or not.  It is very easy. First in the morning you urinate 
into a small cup. A small stick like a pen has one end that you will need to dip in 
your urine.   Each time you test your urine you will look at the little window on 
the stick that will have either an empty circle, a flashing smiley face or a smiley 
face. You will draw a picture of what you see on a paper provided for each day. 
You will have to do this for 10 days, starting from 6th day after you start 
bleeding.  You will need to come get tested on the day you get a smiley face 
that isn’t flashing.  
 You will come to the hospital 3 times once on the 1st or 2nd day of your period, 
once the day your urine test shows a smiley face that isn’t flashing and once 
one week after that.  
 When you come for your first testing session you will get weighted and 
measured. Then you will be given the small soft sensor you were shown at the 
information meeting.  This is about the size of your finger and has a small wire 
coming out.   The woman who helped make these sensors have tried them 
inside themselves and they say it is not uncomfortable. After it is inside you will 
hardly feel it at all.  It will be inside a condom to keep it clean.  You will go into 
the bathroom and go urinate then put it with the condom around it up inside 
your vagina exactly the way the researcher shows you.  If you need help you 
can ask the woman researchers.   It should not hurt and be easy to push inside.  
After you have it in you can put all your clothes on and just leave the wire 
coming out the top of your pants.   
 You will be given a glass of water to drink. Try to drink all of the water. 
 The wire coming out will connect to a machine that measures how much 
pressure you are putting on the muscles around your uterus and the  
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temperature inside.  The small sensor inside you measures this pressure and 
temperature. 
 You will be asked to lift a basket that has a load in it less than half what you 
weight or less than 30 kg, off the floor with a head strap.  You will do it 3 times.   
 After that you will put on a long skirt that covers your legs and remove pants if 
you have them on, you should still fell very well covered.  No one will need to 
look directly at your private areas.  You will lay on a table on your back with 
your feet supported up on the wall.  The researcher will sit next to you.  She will 
gently put the ultrasound machine like you have seen in the pictures at the 
information meeting on your skin up between your legs.  This is the same as 
the way we use the machine to see babies inside their mothers. In this study 
the ultrasound screen will show pictures of your bladder and uterus  and how 
they are moving.  The pictures will look like the ones shown you at the meeting. 
 You will be asked to do six tasks: 
1. Hold your breath and push like you were trying to pass gas. 
2. Tighten the muscles around your vaginal opening like you are trying not to 
pee.  
3.  Cough 
4.  Try to lift up on a head strap while laying down, using your arms and head to 
pull, but not pushing with your feet, slowly pulling harder and harder for 10 
seconds and then relax slowly for 3 seconds.  
5. Lift up against the head strap with your head and arms and you can push with 
your legs slowly pulling harder and harder for 10 seconds and then relax for 3 
seconds.  
6. Lift up against the head strap with your head and arms, and you can push 
with your legs.  This time you will pull up quickly and with strong force. 
 
All these things will put gentle pressure on the muscles that hold your uterus 
up, just like the work you do at home does.  The researcher will be able to see 
how they move and react to the pressure. You don’t have to worry about 
remembering what to do.  The lady researcher will tell you what you need to do.  
Just follow her instructions carefully. Each test will be repeated 3 times. It will 
take about an hour to do all the tests.   
 There will be a camera taking pictures that do not show your private parts or 
face.  It will only take pictures of the activity you are doing.   
 You will have to come 3 times for the testing the second and third time you 
don’t have to lift the basket. All you have to do is the tasks laying on the table. 
 Each time you come for testing you will get 500 Nrs, for a total of 1500 Nrs and 
the last day you will be given the skirt you choose to wear for the testing.  
 You will also get tea and bread or biscuits at the hospital canteen.  
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 All the information we get about you will be kept very secret only the researcher 
will have a key to the place the records are kept. Only this form where you sign 
your name will have your name on it.  You will be given a code number and all 
the rest of the records will only use the code not your name. This way people 
will not be able to read about the study later and know about your private 
information. 
 The researchers will need to have your cell phone number to call you and 
remind you when to come for the testing.  No one from the study will call you 
for any other reason or call you after the study is done unless you request a 
call. 
 
Risks 
Being in this study is no more risky than doing your daily work at home. The 
doctor visits are not more risky than normal doctor visits. You may get sore and 
tired muscle from some of the activities.  The Ultrasound has no known risks of 
injury. The	vaginal	pressure	sensor	my	cause	some	discomfort	or	irritation	to	the	skin.		
The	vaginal	sensor	will	be	in	a	latex	free	condom	and	may	feel	uncomfortable	even	with	
the	use	of		hyper	allergic	lubricant	to	help	with	insertion	as	needed.		Cross	
contamination	is	highly	unlikely	due	to	the	standard	universal	precautions	taken.	You	
will	be	using	condoms	for	sexual	activity	during	the	study	so	the	chances	of	getting	
pregnant	are	low.			
  
 
Benefits 
 
You will get the benefit of 2 free doctor visits.  You will learn a lot about yourself 
and how your body works, and how to prevent your uterus from falling down and 
out of your body.   Because of your help with the study researchers will be able to 
learn and apply new knowledge in how to prevent and handle the problem of fallen 
uterus in Nepal and around the world. You will also get 1500 Nrs and a long simple 
skirt to keep.  
 
Participants rights 
 
No one will try to force you to be a part of the study if you do not want to be.  Only 
if you really want to be involved and sign the this paper will you be able to 
participate.  If you change your mind you can stop any time and there will be no  
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problem.  However you only get the 500 Nrs when you come for each the testing 
and do all the tasks, and the skirt if you complete the study. 
 
Confidentiality 
 
All your names will be kept secret.  No one will be given your personal information 
unless you write down for us that it is ok to give you name to someone else.  If the 
results of the study are printed in a magazine or book your name will never be in 
the printed article.   
 
Cost / Compensation 
 
There is no cost for participating in this study. Each person will receive 500 Nrs 
for each of the 3 sessions for a total of 1500 Nrs possible for participating in the 
entire study.  This is help pay for your travel to get to the study sessions, and for 
your time and energy used in the activities.  You can also keep the skirt you use 
during the testing to cover your legs for privacy. 
 
Impartial Third party 
 
If you want to complain or have any questions about this study but you are not 
comfortable talking to the researchers you may contact the Administration Office of 
Scheer Memorial Hospital  977 11 66 1111 / 1112 you can speak to the Administrative 
secretary Junu Manandhar
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Informed consent statement 
 
I have read this consent form or it has been read to me and explained by the 
researchers.  My questions regarding the study have been answered so am able 
to understand.  I want to participate as a subject in this study.  Signing this consent 
document does not waive my rights nor does it release the investigators, 
institutions, or sponsors from their responsibilities.  I may call Uma Thapa  or 
Yvonne Biswokarma during regular office hours at 977 11 66 1111 / 1112 if I have 
additional questions or concerns.  During non-office hours messages can be left 
at this number.  
 
Must be done in the presence of the third party after they have interviewed the 
subject. 
 
 I have received a copy of this consent form and I understand it and wish to be 
included as a subject in this study.    
 
__________________                                 ______________ 
Signature or thumb print of Subject                  Date 
 
 
 
Subjects Cell Phone number: _______________________________________ 
 
 
 
INVESTIGATOR’S STATEMENT 
I have reviewed the consent form with the person signing above.  I have explained 
potential risks and benefits of the study. 
 
 
Signature of Investigator  ___________________    
Date _____________ 
Signature of Translator ____________________________ 
Date:_________________ 
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Third Party check for full understanding of the potential subject 
 
Instructions: This section to be completed by a different female assistant who 
was not in the room while the potential subject was being given the information 
from this consent form by the investigators.  Choose at least 3 of the questions 
randomly from the list below and verbally ask the woman clearly in her native 
tongue to be sure they have understood the intent and content of this informed 
consent form. If their answers show appropriate understanding please mark with 
check mark √  if not with an X.  The subject should know without prompting or 
reading their paper. 
 
1. What do you think the study is about? _________ 
2. How many times will you need to come for testing? (correct answer is 3) 
______ 
3. Why do you need to see a bone doctor and woman’s doctor before you can be in 
the study? _________ 
4. What are the risks of being in the study?  _________ 
5. What are the benefits of being in the study?_________ 
6. Did the researcher answer all your questions?_________ 
7. What is an example of the tasks you will have to do in the study? ______ 
8. Can you be in the study if you are pregnant?  ______ 
9. Can you be in the study if you have back pain that impairs your daily work?____ 
10. Will there be men in the room while you get tested?_______ 
11. What will the Ultrasound pictures show?_______ 
12. Where will you put the sensor that tests the pressure inside you while you are 
lifting? ________  
 
I witnessed ____________________________ (subjects printed name) provide 
their  signature of thumbprint  on page 6 was done in my presence. The subject was 
able to correctly answer the questions asked of her without difficulty.  I believe 
she understands the content of this consent form and is voluntarily agreeing to 
participate in this study. 
 
Signature of third party: _____________________________Date: _________ 
Printed Name of Third party:_______________________________________  
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Informed Consent:                   YES          NO                       (Circle Correct Response) 
Subject Number: 
General demographic information: 
1. Name:         DOB: 
2. Female      yes   no  
3. Ethnicity:       
4. Religion:  
5. Weight: 
6. Is you home Rural or Urban?        Describe:  
Exclusion:                                                                                              
1. Are you pregnant or any chance of being pregnant ?    Yes     no  
2. Are you using  any form of birth control?    Yes   No       Describe: 
3. Have you ever been pregnant? Yes  No   Describe: 
4. Abortions:                      Miscarriages:                      At what gestational age: 
5. Deliveries:                       Vaginal:   Caesarian sections: 
6. Do you have any pelvic pain?   Yes  No    Describe: 
7. You have trouble holding your urine?  Yes  No   Describe: 
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8. Do you have frequent constipation?  Yes  No   Describe: 
9. Have you ever been told your uterus is falling down into your vagina? Yes  No   
Describe: 
10. Do you have pelvic or low back pain during your period that limits you function?          
Yes  No   Describe: 
11. Do you have irregular periods?  Yes  No     
12. Have you had chronic or recurring respiratory infections of cough? Yes  No   
Describe: 
13. Do you have any allergies? Yes  No   Describe: 
14. Do you have any back problems that limit your ability to work? Yes  No   
Describe: 
15. Do you have any neck problems that limit your ability to work? Yes  No   
Describe: 
16. Do you have frequent head aches that limit your ability to work? Yes  No   
Describe: 
17. Do you have any other physical pain or conditions that effect you ability to carry a 
load? Yes  No   Describe:  
18. Do you have any nerve problems or bones problems?        Yes  No   Describe: 
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19. Have you had any history of bladder cancer? Yes  No  
Gynecological and Carrying history questions 
1. How many days is your regular cycle? _____ 
2. When was your last period?                                
3. How long are your typical periods? 
4. When was your last pelvic exam? 
5. **Have you done frequent load bearing using a doko and namlo? Describe: 
6. How much weight do you can you carry? 
7.  How often do you carry loads? 
8. When was the last time you carried a load? 
9. Do you smoke?  Yes  No    
** Doko is a traditional cone shaped Basket used for carrying loads with a head strap.  
Namlo is the head strap used to carry loads in the traditional way in the hilly and 
mountainous regions of Nepal. 
Decision:  □ Include in the study                   □ Exclude from the study 
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;xdlt kq 
æ/h:jnf rqmsf] ljleGg ;dodf s[ltd x]8 ljol/ª /fv]/ ul/g] kl/If0f / 
k]lNes ˆnf]/ -cfª_ sf] larngÆ 
pb]Zo / k|lqmof  
tkfO{sf] /h:jnf rqm el/df s'g} a:t' prfNbf tNnf] k]6 -cfª_ df kg{] bjfj 
/ o;sf] c;/ ;DaGwdf ljZn]if0f ul/g] cg';Gwfgdf ;xefuL x'g cfu|x ul/G5 . 
o; cg';Gwfgdf ;xeflu x'g l:jsf/ ug{' clw tkfO{n] s]lx k[i7x?df tkfO{n] uXf} 
a:t' prfNg] cEof;, :jf:Yo, /hZjnf rqm / cGo k|hgg :jf:Yo tyf kfl/jfl/s 
/ hg;+flVolsotf ;DalGw ;j{]If0f k|Zgx?sf] hjfkm lbg' kg{]5 . cWoogdf ;xeflu 
x'g tkfO{ ue{jtL jf cfufdL # b]vL $ xKtf ;Dd ue{jtL gx'g] cj:yfsf] x'g' kb{5 
. ;xeflu x'bf tkfO{n] g]kfnL k/Dk/fs]f 8f]sf] gfDnf]sf] k|of]u ul/ s]lx tf}n p7fpg' 
kg{] x'G5 . hf] tkfO{sf] zl//sf] tf}nsf] $)Ü jf jf #) s]=hL eGbf al9 x'b}g 
o;sf cnjf tkfO{n] ^ j6f ;fdfGo sfdx? h:t} vf]Sg' , ws]Gg', cfª v'Drfpg', 
6's'Ss a:;]/ uf]8f v;fg{], nfdf] :jf; tfg]/ kmfGg'_ h;n] tkfO{sf] cfªdf lelq 
bjfa l;h{gf ug{ ;Sb5g\ To:tf sfdx? pQfgf] k/]/ ug{'kg{] x'G5 . tkfO{nfO{ 
cf/fdsf] ;dodf cN6«f;fp08 ug{ nufO{g]5 . h;df tkfO{sf] cfª k]lNes ˆnf]/sf] 
/]s8 ul/g]5 . tkfO{sf] cfªdf k/]sf] bjfjsf] kl/If0f ug{ of]gLsf] lelq Pp6f 
;]G;/ /fvL ;f] sf] hfgsf/L b]vfpg tkfO{sf] sk8fdf Pp6f lSnk em'08fPsf] x'g]5 
. o; ;]G;/n] cfªdf k/]sf] lelq bjfjsf] lg/Gt/ hfgsf/L lbg]5 . of] ;]G;/ w]/} 
dlxnfx?df k|of]u ul/;s]sf] 5 / cf/fdbflo tyf c?n] ;lhn} cg'dfg ug{ ;Sg] 
x'b}g . of] kl/If0fx? ltg k6s ;Dd bf]xf]/fO{g]5 . cfufdL # b]vL $ xKtf ;Dd 
tkfO{n] cfkgf] /hZjnf rqmsf] Wofg k"j{s /]s8{ /fVg'k5{ / k|To]s ljxfg lk;fasf] 
kl/If0f /h:jnfsf] 5}6f}+ lbg b]vL cf]e'n];g lbg ;Dd ug{'kg{]5 . :qL /f]h kl/If0f 
/ xf8 hf]gL{ kl/If0f ul/;s]kl5 dfq tkfO{nfO{ cWoogdf ;dfj]; ul/g]5 h;df 
dlxnf lrlsT;sn] :qL /f]u ;DalGw jf xf8 hf]gL{ ;No lrlsT;s4f/f 3fF6L / 9f8 
tkfO{s]f kfv'/fsf df+zk]zLn] tf}n yfDg] If]dtfsf] kl/If0f x'g]5 . oL kl/If0fx?n] 
tkfO{ cWoogdf ;xefuL x'g pko"Qm x'g'x'G5 jf tkfO{nfO{ cWoogdf ;xeflu u/fpg 
hf]lvd 5 jf 5}g eGg] s'/f lgSof{]n ug{]5 .  ;xeflutfsf nflu 5gf}6 x'g] ;a} 
;Q{ k"/f ePdf tkfO{ afFsL # kl/If0fx? ;xeflu u/fpg] ldlt lbO{g]5 .  
;xeflusf] gfdM   
ldltM  
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cWoogsf] klxnf] lbg tkfO{sf] pd]/, tf}n / prfO{sf] clen]v /flvg] 5. To;kl5 
tkfO{nfO{ lk;fa y}nL vfnL u/fpg nufpg] 5  / kl/If0f ;'?x'g eGbf #) ldg]6 
cl3 !^)z kfgL lkpg] lbO{g] 5 . /h:jnfsf ;do /SQm>fj /f]Sg /f]Sg k|of]u 
ul/g] Kof8 h:t} ;fgf] Tampon	Sensor	nfO{ s08d leq /fv]/ tkfO{nfO{ ;xh 
x'g] ;Dd of]gL leq k7fpg nufO{g] 5 / of] sfd tkfO{n] uf]Ko ?kdf afy?d leq 
ug{ kfpg' x'g]5 . To;kl5 tkfO{sf] zl//sf] tf}nsf] $) k|ltzt jf #) lsnf]u|fd 
eGbf al9 gx'g] tf}n p7fpg nufO{g] 5 . To;kl5 tkfO{n] cGo ltg k6s tf}n 
p7fpg] sfd ug'kg{] 5 h;df 8f]sf] leq tf}n /fv]/ e'O{eGbf dfly ltg k6s p7fpg 
kg{] 5 . o; cjlwdf tf}n p7fpbf k]nlds Knf]/df k/]sf] bjfasf] cf}ift /]s{8 
ul/g] 5 . leQfdf em'8\ofP/ /fv]sf] bjfa dfks -Presure	Sensing_ r§fdf 
v'6f c8\ofP/ 6]an dfyL ptfgf] k/]/ a:g nufOg] 5 . ;f] qmddf tkfO{nfO{ tkfO{sf] 
zl//df sl;nf] ePsf sk8fx? lgsfNg nufP/ zl// k'/} 9flsg] ul/ ufpg nufpg] 
lbO{g] 5 / s[ltd US	Head tkfO{sf] k]lNds Knf]/df /flvg] 5. tkfO{sf] zfl/l/s 
tfkqmd lqmofsnfk cl3 tyf kl5 b'a} k6s lnO{g]5 .  lo ;a} s'/fx? ug{] tkfO{sf] 
ug{ tkfO{sf] dbtsf nfuL Ps dlxnf cg'zGwfg stf{ jf bf]ef;] tkfO{sf] sf]7fdf 
pknAw x'g]5g . To;kl5 tkfO{nfO{ :jf; /f]Sg] / 5f]8\g] u/fO{ k]lNds Çnf]/df 
/flvPsf] US Head ;+u} pQm Knf]/ v'Drfpg nufO{g] 5 / klxn] pleP/ tf}n 
p7fpbfsf] h:t} ptfgf] k/]/ klN6bf klg b'O{k6s tf}n p7fpg nufO{g] 5 . h:df 
tkfO{n] cl3Nnf] lqmofsnfkdf h:t} cfGtl/s bjfa ldnfpg] k|of; ug'{x'g]5 . of] 
nfdf] k|lqmofdf tkfO{n] lrGtf ug{' kb{]g lsgeg] cg';Gwfg stf{n] tkfO{nfO{ a'‰g 
sl7g ePsf] cj:yfdf k|To]s r/0fx? cfkm} k|b{zg u/]/ b]vfpg] 5g . ;a} r/0fx? 
;s]/ cf/fdsf ;dodf k|To]s lqmofsnfkx?sf ;fy} tkfO{sf] lk;fa y}nLsf] :yfg 
/ k]lNds Çnf]/sf] ;+/rgfnfO{ cN6«f;fpG8 lel8of]df /]s{8 ul/g] 5 . k|To]s 
k|of;sf] lardf Psldg]6 cf/fd u/fpb} ltg k6s ;Dd dfkg ul/g] 5 . tkfO{n] 
ug{'ePsf] k|To]s lqmofsnfksf] lel8of] lvlrg] 5 h;df tkfO{sf] lrgf/L cfpg] 
klxrfg v'Ng] tkfO{sf] d'vfs[lt lel8of]df /]s{8 ul/g] 5}g . of] ;Dk'0f{ k|lqmof 
klxnf] k6ssf nfuL () b]lv !@) ldg]6 ;Ddsf] ;do x'g] / To;kl5sf k|To]s 
kl/If0fx? ! 306f al9sf x'g] 5}gg\ .    
tkfO{nfO{ cfjZos lgb{]zgx? ;lxt k|To]s laxfg cfÇgf] lk;fa kl/If0f h;df 
/h:jnfsf] 5}6f}+ lbg b]vL nuftf/ !) lbg ;Dd  lg/Gt/ cjnf]sg / /]s{8 ug{sf 
nfuL cfjZos ;fdflu|x? pknAw u/fOg] 5 . tkfO{ /h:jnf ePsf] ! jf @ lbg 
leq ! k6s, lk;fasf]  LH kl/If0faf6 k|fKt hfgsf/L cg';f/ cf]e'n]zg ePsf] 
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@$ b]vL $* 306f leq bf];|f] k6s / cf]e'n]zg kl5sf] ^ b]vL * lbg leq t];|f] 
k6s ul/ kl/If0fsf nflu # k6s pkl:yt x'g'kg{]5 .  
dfly pNn]lvt ;a} r/0fx?sf] kl/If0f tf]lsPsf] kl/If0f sf]7fleq / ag]kfsf] lz/ 
d]df]l/on c:ktfndf dfq x'g]5 . kl/If0f ;dfKt ePkl5 kl/If0fsf] kl/0ffdsf 
;DaGwdf tkfO{nfO{ 5f]6s/L hfgsf/L lbO{g] 5 . kl/If0fsf nfuL tkfO{ pkl:yt 
x'g'ePsf] lbgx?df tkfO{nfO{ lrof, h'; / gf:tf lbO{g] 5 / k|To]s kl/If0fdf ;xeflu 
x'g cfpbf oftfoft, ;do / tkfO{n] p7fpg' k/]sf] c;xhtf afkt ? %)) lbOg] 
5 .  
 
;xeflusf] cl3Nnf] gfd 
ldlt  
 
 
83 
 
æ/h:jnf rqmsf] ljleGg ;dodf s[ltd x]8 ljol/ª /fv]/ ul/g] kl/If0f / 
k]lNes ˆnf]/ -cfª_ sf] larngÆ 
hf]lvdx?  
o; cWoog vf]hdf ;xeflu x'bfF s]lx hf]lvdx? 5g t/ b}lgs lhjgsf hf]lvd 
eGbf 5}gg\ . 3/df s]lx p7fpg] jf af]Sg] sfd ubf{ x'g ;Sg] 3fp rf]6 h:t} hf]lvd 
x'g ;S5 . v'§fpg] kl/If0fx? -Screening	Test_ sf] hf]lvd k|;'tL ;]jf jf 
xf8 hf]/gL ;]jfsf nfuL ul/g] lgoldt kl/If0f eGbf al9 5}g . s[ltdtf / tf}n 
p7fpg] lqmofsnfkx?sf] sf/0f df+zk]zL b'Vg] jf pQm lqmofsnfksf] w]/} kl5 cGo 
df+;k]zL b'Vg] hf]lvd eg] x'g;Sb5 . cN6«f;fpG8sf] s'g} vf; hf]lvd b]lvb}g. 
of]lg leq /flvg] k|];/ ;]G;/n] eg] s]lx c;xh jf lr8lr8fx6 Nofpg ;S5 olb 
tkfO{sf] 5fnfdf s08ddf k|of]u ePsf /;fogx?sf] c;/ k5{ eg] . o;f] ePdf 
Nof6]S; k|mL s08d -latex	Free	Condom_ sf] k|of]u / PnhL{ sd ug{] 
cf}ifwLsf] k|of]u ul/g] 5 . 
kmfO{bfx?  
lgz'Ns kl/If0fsf cnfjf o; cWoogdf ;xeflu x'Fbf tkfO{nfO{ s'g} k|ToIf kmfO{bf 
5}g tyfkL tkfO{sf] pT;'stf ;lxtsf] ;xeflutfn] ;+;f/e/ ;d:ofsf] ?kdf b]lvPsf] 
k]lNds Çnf]/sf] ljrngsf d'Vo tTjx?sf] af/]df xfdLnfO{ ljlzi6 1fg k|fKt ug{ 
dbt x'g]5 . k]lNds Çnf]/sf] larng af6 dlxnfx?nfO{  hf]ufpg cg';Gwfg stf{ 
cem yk hfgsf/Lx? ;+sng ug{ rfxG5g\ .  
 
;xeflusf clwsf/x?  
;xeflutf k'0f{tof :j]lR5s xf] . lagf ;hfo cWoogdf ;xeflutf Nofpg ;lsg] 
5 .  
uf]klgotf  
;a} clen]v uf]Ko /flvg] 5g\ . tkfO{sf] lnlvt cg'dlt lagf o; cWoogdf /x]sf] 
tkfO{sf] ;+nUgtfsf] af/]df c?nfO{ elgg] 5}g . cWoog kZrft k|sflzt x'g] s'g} 
klg sfuhftdf tkfO{sf] kl/ro v'Ng] s'g} klg s'/fx? ;dfa]z ul/g] 5}g .  
 
nfut÷Ifltk'lt{   
cWoogdf ;xefuL z'Ns jf nufgL cfjZos 5}g . ;xeflun] k|To]s # r/0fsf] 
kl/If0fdf ;xeflu eP afkt k|To]ssf] ? %)) sf b/n] cWoog cjlwe/sf] Psd'i6 
? !%)).– k|fKt ug{] 5g . kl/If0f :yndf pkl:yt ePsf k|To]s lbg laxfg lrof 
gf:tf pknAw u/fO{g] 5 .  
;xefuLsf] gfdM  
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ldltM 
 
lgZkIf t];|f] AolQm÷;+:yf÷ ;d"x  
o; cWoogdf ;xefuL x'g] ;Gbe{df olb tkfO{Fn] rfxg' ePdf s'g} kZgx?÷lh1f;fx? 
/ ;'emfjx? lbgsf nflu lgZkIf t];|f] AolQm÷;+:yf ;+u ;Dks{ ug{ ;Sg'x'g]5 . 
h;sf nflu lgDg 7]ufgf k|of]u ug{ ;Sg'x'g]5 .  
Office	of	Patient	Relations	at	Loma	Linda	University.	Loma	
Linda	 University	 Medical	 Center,	 Loma	 Linda	 California	
92354.	Phone	001-909-558-4647 
;xeflusf] gfdM =================== 
ldltM==================  
 
 
 
 
æ/h:jnf rqmsf] ljleGg ;dodf s[ltd x]8 ljol/ª /fv]/ ul/g] kl/If0f / 
k]lNes ˆnf]/ -cfª_ sf] larngÆ 
d}n] o; cg';Gwfg ;+u ;DalGwt ;a} ljifo a:t'x? a9] / cg';Gwfg stf{sf] 
df}lvs AofVof klg ;'g] . cg';Gwfg ;+u ;DalGwt d]/f] lh1fzfx?sf] ;Gt'i6 x'g] 
u/L hjfkm klg kfFP . cg';Gwfgsf ;DaGwdf d}n] a'em\g ;Sg] u/L AoVof ul/Psf] 
xf] / o;df d ;xeflux x'g /fhL 5' . o; ;xdlt kqdf x:tfIf/ ug{'sf] cy{ d 
/ cg';Gwfg stf{, ;+:yf jf bftf cfˆgf] clwsf/ / st{Aoaf6 5'6\sf/f kfpg]5g\ 
eGg] xf]Og\ cg';Gwfg ;+u ;DalGwt d]/f] yk lh1fsf nflu d}n] o; cg';Gwfgsf 
d'Vo AolQmnfO{ Everett B. Lohman III, DSc,PT,OCS df sfo{no ;do 
leq ))!–()(–%%*–!))) yk -lj:tf/nfO{g_ *#!&! df l;wf ;Dks{ jf 
sfo{no ;do afx]s ;f]lx gDa/df :j/ va/ -Voice mail_ ug{] 5' . 
d}n] of] ;xdlt kqsf] k|ltlnlk a'lemlnPF .  
 
 
==============================      ======================== 
;xefuLsf] x:tfIf/        ldlt 
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cg';Gwfg stf{sf] egfO{  
;xeflusf] x:tfIf/ ;lxtsf] ;xdtL kq d}+n] k'glj{rf/ u/]+ . d}n] cWoogsf 
;Defljt hf]lvdx? / kmfObfx?sf] af/]df ;xeflunfO{ atfPsf] 5' .  
 
 
=======================================    
 ldltM============================ 
cg';Gwfg stf{sf] x:tfIf/  
  
 
 
86 
æ/h:jnf rqmsf] ljleGg ;dodf s[ltd x]8 ljol/ª /fv]/ ul/g] kl/If0f / k]lNes ˆnf]/ -
cfª_ sf] larngÆ 
 
;xdtL                   5                 5}g         ;xL pQ/df 3]/f nufpg'xf];\ 	
;xefuLsf] gDa/ 	
;fdfGo hg;f+lvsLo hfgsf/L  
 
!= gfd                                       hGd ldltM  
@= dlxnf       xf]       xf]Og  
#= hghfltotf  
$= wd{  
%= tf}n  
^= tkfO{sf] zx/ ;x/df  ls ufFpdf<              j0f{g ug{'xf];\  
 
5gf}6  
!= s] tkfO{ ue{jtL x'g'x'G5 jf uj{jtL cj:yfdf x'g] cj:yfdf x'g' x'G5 <        
                                                 5'         5}g  
 
@= ue{ lg/f]wssf nflu s]lx k|of]u ug{'ePsf] 5 <       5         5}g      j0f{g 
ug{'xf];\   
 
#= s] tkfO{ o; cl3 ue{jtL x'g'x'GYof] <         lyP         lyOg     j0f{g ug{'xf];\  
  
$= ue{ktg             lar}df v]/ uPsf]           slt dlxgfdf  
 
%= ;'Ts]/L        ;fdfGo        d]lzg k|of]u  
 
^= s] tkfO{sf] cfª b'V5 < b'V5       b'Vb}g j0f{g ug{'xf]; . 
  
&= lk;fa /f]Sg ;d:of 5 <         5         5}g      j0f{g ug{'xf];\  
  
*= s] tkfO{nfO{ af/Daf/ slAhot x'G5 <     x'G5      x'b}g    j0f{g ug{'xf];\  
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(= cfªsf cª\u ;/]sf] kQf kfpg' ePsf] 5<  5         5}g      j0f{g ug{'xf];\   
 
!)= slxNo} cfª jf s§L b'v]/ sfd ug{ g;Sg' ePsf] 5 <    5         5}g      j0f{g 
ug{'xf];\   
!!= s] /hZjnf clgoldt x'G5 < x'G5      x'b}g 
!@= s] tkfO{nfO{ Zjf; k|Zjf;df v/faL eO{ vf]sL nfUg] u5{ <        u5{  ub{}g  
 
!#= s] tkfO{nfO{ s'g} Pnlh{ 5<            5      5}g    pNn]v ug{'xf];\  
 
!$= s] tkfO{nfO{ 9f8 b'Vg] u/]sf] 5<       5      5}g    pNn]v ug{'xf];\  
 
!%= s] tkfO{nfO{ 3fF6Lsf] ;d:of 5 <      5      5}g    pNn]v ug{'xf];\  
 
!^= s] tkfO{nfO{ af/Daf/ 6fpsf] b'Vg] u/]sf] 5<    u5{     ub{}g    pNn]v ug{'xf];\ .  
 
:qL/f]u / tf}n p7fpg] cEof; ;DaGwL  
!= lgoldt /hZjnf rqm slt lbgsf] 5<  
 
@= cl3Nnf] /hZjnf rqmsf] clGtd lbg slxn] lyof]<  
 
#= ljz]if cj:yf slt cjlwsf] 5 <  
 
$= clGtd k6s÷kl5Nnf] k6s slxnf] cfª kl/If0f ug'{ePsf] lyof]<  
 
%= s] tkfO{nfO{ gfDnf] 8f]sf] ;lxt ef/L af]Sg' x'G5 < pNn]v ug{'xf];\ .  
 
^= slt tf}t prfNg ;Sg'x'G5 <  
 
&= slt k6s tf}n prfNg' x'G5 <  
 
*= s] w'|d|kfg ug{'x'G5 < u5{'     ulb{g .  
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APPENDIX B 
STUDY RECRUITMENT POSTER (ENGLISH AND NEPALI) 
Loma Linda University 
School of Allied health Professionals 
Department of Physical Therapy 
In conjunction with Scheer Memorial Hospital 
 
RESEARCH PROJECT 
 
“Displacement of the pelvic floor with Isometric Simulation of Head 
Bearing Lifting at 3 Crucial Points in the Menstrual Cycle.” 
  
Researchers need YOUR participation help us identify 
lifestyle risk factors that could be responsible for fallen 
uterus in young  woman: 
1. If you are a woman between the ages of 18-30. 
2. You don’t have any health problems that effect your ability 
to lift heavy weights. 
3. You want to learn more about your body and how to protect 
yourself and others from developing a fallen uterus.  
4. Participation in this study will involve 3, one hour sessions 
over 3-4 weeks. 
5. Participants in this research study perform moderate 
traditional lifting tasks and that will allow the researchers to 
study the effects of lifting on the pelvic floor muscles during 
each phase of the menstrual cycle.  
6. To find out more you can come to the Scheer Memorial 
Hospital Conference room on Friday, January 17 at 12 
O’clock for a hour information and education program and 
get a free lunch.  
7. If you do participate in the study you will be paid for you 
time.  
 
Please contact Uma Thapa RN at 977 11 66 1111/1112  Scheer 
Memorial Hospital or email umathapa7@gmail.com or ygray@llu.eduif 
you are interested and would like more information. 
 
Your participation is much appreciated. 
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nf]df ln08f ljZjljBfno 
:s"n ckm Pln8 x]Ny k|f]km];gN; 
l8kf6{d]G6 ckm lkmlhsn y]/fkL 
tyf zL/ d]df]l/on c:ktfnsf] ;+o"Qm k|of;df ;~rflnt  
 
cg';Gwfg kl/of]hgf  
 
/h:jnf rqmsf] ltgj6f dxTjk'0f{ ;dodf s[ltd x]8 ljol/ª /fVbf k]lNes 
Çnf]/ -cfª_ df kg{] k|efj -;g{] jf emg{]_      
 
jo:s dlxnfx?df cfª v:g] ;d:ofsf lhDd]jf/ hf]lvd– tTjx? kQf nufpg ul/g] 
cg';Gwfgdf tkfO{sf] ;xeflutfsf nflu cjZos zt{x?M  
!= tkfO{ !* b]lv #) jif{sf] dlxnf x'g'k5{ .  
@= ux|f} a:t' prfNg tkfO{sf] :jf:Yo ;d:of x'g'x'b}g .  
#= tkfO{ cfkm\gf] z/L/sf] af/]df hfGg rfxg' x'G5 / cfª v:g]÷;g{] ;d:ofaf6 
cfkm" / c?nfO{ arfpg rfxg'x'G5 .  
$= cg';Gwfgdf ;xeflu x'Fbf # b]lv $ xKtf leq k|To]s k6s ! 306f cjlwsf] +tLg 
k6s k/LIf0fdf ;fd]n xg'x'g]5 .  
%= cg';Gwfgdf ;xeflu x'Fbf g]kfndf k/Dk/fut ?kdf dlxnfn] p7fpg] u/]sf - 
h:t} 8f]sf]–gfDnf]_ a:t'x? p7fpg] sfd ug{'kg{] x'G5 . o;/L a:t'x? p7fFpbf 
/hZjnf rqm leq cfªsf] df+zk]zLdf kg{] k|efjsf af/]df cg';Gwfgstf{n] cWoog 
ug{]5g\ .  
^= yk hfgsf/Lsf nflu tkfO{ hgj/L !& tfl/v z'qmjf/ !@ ah] zL/ d]df]l/on 
c:ktfnsf] ;Dd]ng sIffdf pkl:yt x'g ;Sg'x'g]5 . Ps 306f nfdf] 5nkmndf 
;xefuL x'Fbf tkfO{nfO{ lgMz'Ns vfgfsf] Aoj:yf ul/Psf] 5 .  
&= cWoogdf ;xefuL x'g /fhL x'g' ePdf tkfO{nfO{ ;xefuL eQf lbOg] 5 .  
olb tkfO{ cWoogdf ;xefuL x'g OR5's x'g'x'G5 / yk hfgsf/L rfxg' x'G5 eg] 
s[kof lgDg 7]ufgfdf ;Dks{ ug{ ;Sg'x'g]5 .  
zL/ d]df]l/on c:ktfn  
pdf yfkf -RN_ (&&!!^^!!!!÷!!!@  
Od]n M umathapa7@gmail.com or ygray@llu.edu 
 
tkfO{sf] ;xeflutf ;x|flgo /xg]5M  
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APPENDIX C 
PELVIC FLOOR DATA COLLECTION SHEET  
Nepal	Pelvic	Floor	Study	Data	Collection	Sheet	
Participant identifier: _______________________________________________ 
Date: __________________ 
IAP Sensor number:___________________ 
Height: _______________ 
Weight: ______________ 
Date of birth: ________________ 
Session (Circle): Session 1/Session 2/Session 3 
Circle phase below:  
Early Follicular phase (menstruation), Ovulation phase, Luteal phase   
Subfolder: my documents/Nepal data/<participant identifier>/Session#/ 
 
Trial File name Notes 
Doka lift 
 
P<      >_Lift Peak to peak voltage= 
1- 
2- 
3- 
4- 
5- 
6- 
Valsalva/bear down 
(moderate 5/10) 
P<      >_Valsalva  
PFM contraction 
(moderate 5/10) 
P<      >_PFM  
Cough (voluntary) 
strong 8/10 
P<      >_Cough  
Supine lift – Ramp 
5-10 sec up to target 
P<      >_Ramp  
Supine lift –Ballistic 
up to target 
P<      >_Ballistic  
Supine lift –Ballistic 
– Pre-activate PFM 
Up to target 
P<      >_PFMBallistic  
Notes 
• Insert Participant identifier number between <> 
• Name video file same as data file 
• Target supine should be ~50% of peak during doka lift 
• Pressure analysis – in Biopac software, only concerned about baseline to peak 
pressure change 
• Nulliparous or not? 
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APPENDIX D 
OB/GYN SCREENING FORM 
OB/GYN Screening Form for Study Titled “Displacement of the Pelvic floor with 
Isometric Simulation of Head Bearing Lifting at 3 Crucial Points in the Menstrual Cycle”  
 
To filled out by the OB/GYN  
 
Date:  ____________________ 
 
Patients Name:  
Age:                               
D.O.B:________________________ 
 
Gender:   Female  
When was the last period 
Medical History: Circle all that apply.  
  
 History of Rape   
 Heavy menstrual bleeding 
 Abdominal distortion 
 Pelvic pressure 
 Low back pain 
dyspareunia 
 Infertility 
 Frequent urination 
 Constipation 
 Miscarriage or premature labor 
 Pain with defecation, urination  
 pelvic mass 
 STI 
 Anemic 
 Hormonal cycles 
 Parity Index:  G2  P1   A1 
 Cycles (3-4 /28-30)   
Family Planning Method: 
 CI 
Copper T  
Depo  
Norplant  
Oral contraceptive  
Condoms 
Rhythm Method 
  
 
Pelvic Exam  
1. Observation and the speculum exam 
 
 
POP-Q stage:  
 
 
Is there any abnormal vaginal conditions?    
warts 
discharge 
tissue damage 
scaring from episiotomy or other injury 
Intact hymen 
HPV, Herpes, Chlamydia 
Vulvovaginitis  
Patient unable to contract the pelvic floor 
muscles 
 
2. Bimanual exam 
Circle all that apply.  
 Vaginismus? level 1-5? 
 POP-Q level?  (level of prolapse) 
 Endometriosis (causing pain during 
period that effects function?)  
 Uterine fibroids? 
 Uterine conditions 
 Ovarian condition 
3. Recto-Vaginal Exam  
Complete if indicated.  
 
I certify that I have examined this woman and 
she has no conditions that could limit her ability 
to participate in this study. 
 
 
Physician’s 
Signature:__________________________ 
 
Date:_________________________
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APPENDIX E 
LOMA LINDA UNIVERSITY INSTITUTIONAL REVIEW BOARD APPROVAL  
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APPENDIX F 
NEPAL HEALTH RESEARCH COUNCIL APPROVAL 
 
 
